Transcription	B-protein
factors	I-protein
Sp1	B-protein
and	O
AP-2	B-protein
mediate	O
induction	O
of	O
acid	B-protein
sphingomyelinase	I-protein
during	O
monocytic	O
differentiation	O
.	O

Cells	O
from	O
the	O
human	B-cell_line
monocytic	I-cell_line
leukemia	I-cell_line
cell	I-cell_line
line	I-cell_line
THP-1	B-cell_line
differentiate	O
towards	O
a	O
macrophage-like	O
phenotype	O
when	O
stimulated	O
with	O
phorbol	O
12-myristate	O
-13-	O
acetate	O
(	O
PMA	O
)	O
,	O
1	O
,	O
25-dihydroxy-vitamin	O
D3	O
,	O
and	O
various	O
other	O
agents	O
.	O

We	O
demonstrate	O
here	O
that	O
the	O
expression	O
of	O
the	O
lysosomal	B-protein
enzyme	I-protein
acid	B-protein
sphingomyelinase	I-protein
(	O
ASM	O
;	O
E.C.3.1.4.12	O
)	O
is	O
induced	O
during	O
this	O
process	O
and	O
is	O
strongly	O
elevated	O
in	O
differentiated	O
THP-1	B-cell_line
cells	I-cell_line
,	O
as	O
well	O
as	O
in	O
differentiated	O
human	B-cell_type
mononuclear	I-cell_type
phagocytes	I-cell_type
.	O

Using	O
Northern	O
blotting	O
,	O
RNase	B-protein
protection	O
assay	O
,	O
and	O
nuclear	O
run-on	O
analyses	O
,	O
we	O
show	O
that	O
the	O
up-regulation	O
of	O
ASM	O
expression	O
is	O
regulated	O
mainly	O
at	O
the	O
level	O
of	O
transcription	O
and	O
that	O
new	O
protein	O
synthesis	O
is	O
required	O
for	O
enhanced	O
ASM	O
activity	O
.	O

This	O
cell-type	O
specific	O
induction	O
by	O
PMA	O
treatment	O
was	O
further	O
investigated	O
with	O
respect	O
to	O
transcriptional	O
control	O
.	O

A	O
series	O
of	O
5	B-DNA
'	I-DNA
deletion	I-DNA
derivatives	I-DNA
of	O
the	O
upstream	B-DNA
regulatory	I-DNA
region	I-DNA
were	O
used	O
in	O
transient	O
transfection	O
assays	O
to	O
identify	O
promoter	B-DNA
elements	I-DNA
required	O
for	O
basal	O
and	O
inducible	O
gene	O
expression	O
.	O

A	O
PMA	B-DNA
responsive	I-DNA
element	I-DNA
was	O
localized	O
to	O
a	O
region	O
between	O
-319	B-DNA
and	I-DNA
-219	I-DNA
bp	I-DNA
upstream	I-DNA
of	O
the	O
initiation	O
codon	O
and	O
co-transfections	O
with	O
transcription	B-DNA
factor	I-DNA
expression	I-DNA
plasmids	I-DNA
for	O
AP-2	B-protein
and	O
Sp1	B-protein
resulted	O
in	O
augmented	O
ASM	O
promoter	O
activity	O
,	O
which	O
was	O
abolished	O
when	O
the	O
binding	B-DNA
sites	I-DNA
for	O
these	O
two	O
factors	O
were	O
deleted	O
.	O

Using	O
electrophoretic	O
mobility	O
shift	O
assays	O
and	O
supershift	O
assays	O
we	O
demonstrate	O
that	O
this	O
region	O
is	O
specifically	O
bound	O
by	O
Sp1	B-protein
and	O
AP-2	B-protein
.	O

These	O
factors	O
are	O
present	O
in	O
nuclear	O
extracts	O
prepared	O
from	O
both	O
induced	O
and	O
uninduced	O
THP-1	B-cell_line
cells	I-cell_line
.	O

However	O
,	O
the	O
intensity	O
of	O
the	O
complex	O
formed	O
appeared	O
to	O
increase	O
when	O
nuclear	O
extracts	O
from	O
PMA-treated	B-cell_line
cells	I-cell_line
were	O
used	O
.	O

From	O
these	O
studies	O
,	O
we	O
conclude	O
that	O
a	O
concerted	O
action	O
of	O
the	O
transcription	B-protein
factors	I-protein
AP-2	B-protein
and	O
Sp1	B-protein
is	O
essential	O
for	O
the	O
up	O
-regulation	O
of	O
ASM	O
expression	O
during	O
the	O
process	O
of	O
macrophage	O
differentiation	O
.	O

ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
Transcription	NULL
factors	NULL
Sp1	NULL
and	NULL
AP-2	NULL
mediate	NULL
induction	NULL
of	NULL
acid	NULL
sphingomyelinase	NULL
during	NULL
monocytic	NULL
differentiation	NULL
Thomas	NULL
Langmann	NULL
,	NULL
*	NULL
Christa	NULL
Buechler	NULL
,	NULL
*	NULL
Stefan	NULL
Ries	NULL
,	NULL
*	NULL
Andreas	NULL
Schaeffier	NULL
,	NULL
*	NULL
Charalampos	NULL
Aslanidis	NULL
,	NULL
*	NULL
Marion	NULL
Schuierer	NULL
,	NULL
!	NULL

Manfred	NULL
Weiler	NULL
,	NULL
}	NULL
Konrad	NULL
Sandhoff	NULL
,	NULL
$	NULL
Pieter	NULL
J.	NULL
de	NULL
Jong	NULL
,	NULL
**	NULL
and	NULL
Gerd	NULL
Schmitz**	NULL
Institut	NULL
fir	NULL
Klinische	NULL
Chemie	NULL
und	NULL
Laboratoriumsmedizin	NULL
,	NULL
*	NULL
and	NULL
Institut	NULL
fiir	NULL
Klinikum	NULL
der	NULL
Universitit	NULL
Regensburg	NULL
,	NULL
D-93042	NULL
Regensburg	NULL
,	NULL
Germany	NULL
;	NULL
Institut	NULL
fiir	NULL
Organische	NULL
Chemie	NULL
und	NULL
Biochemie	NULL
,	NULL
$	NULL
Universitit	NULL
Bonn	NULL
,	NULL
D-53121	NULL
Bonn	NULL
,	NULL
Germany	NULL
;	NULL
and	NULL
Human	NULL
Genetics	NULL
Department	NULL
,	NULL
**	NULL
Roswell	NULL
Park	NULL
Cancer	NULL
Institute	NULL
,	NULL
Buffalo	NULL
,	NULL
NY14263	NULL
Abstract	NULL
Cells	NULL
from	NULL
the	NULL
human	NULL
monocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
THP-1	NULL
differentiate	NULL
towards	NULL
a	NULL
macrophage	NULL
{	NULL
Jike	NULL
phenotype	NULL
when	NULL
stimulated	NULL
with	NULL
phorbol	NULL
12-myristate-l3-acetate	NULL
(	NULL
PMA	NULL
)	NULL
,	NULL
1,25-dihydroxy-vitamin	NULL
D	NULL
;	NULL
,	NULL
and	NULL
various	NULL
other	NULL
agents	NULL
.	NULL

We	NULL
demonstrate	NULL
here	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
lysosomal	NULL
enzyme	NULL
acid	NULL
sphingomyelinase	NULL
(	NULL
ASM	NULL
;	NULL
E.C	NULL
.	NULL

3.1.4.12	NULL
)	NULL
is	NULL
induced	NULL
during	NULL
this	NULL
process	NULL
and	NULL
is	NULL
strongly	NULL
elevated	NULL
in	NULL
differentiated	NULL
THP-1	NULL
cells	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
differentiated	NULL
human	NULL
mononuclear	NULL
phagocytes	NULL
.	NULL

Using	NULL
Northern	NULL
blotting	NULL
,	NULL
RNase	NULL
protection	NULL
assay	NULL
,	NULL
and	NULL
nuclear	NULL
run-on	NULL
analyses	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
up-regulation	NULL
of	NULL
ASM	NULL
expression	NULL
is	NULL
regulated	NULL
mainly	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
and	NULL
that	NULL
new	NULL
protein	NULL
synthesis	NULL
is	NULL
required	NULL
for	NULL
enhanced	NULL
ASM	NULL
activity	NULL
.	NULL

This	NULL
cell-type	NULL
specific	NULL
induction	NULL
by	NULL
PMA	NULL
treatment	NULL
was	NULL
further	NULL
investigated	NULL
with	NULL
respect	NULL
to	NULL
transcriptional	NULL
control	NULL
.	NULL

A	NULL
series	NULL
of	NULL
5	NULL
'	NULL
deletion	NULL
derivatives	NULL
of	NULL
the	NULL
upstream	NULL
regulatory	NULL
region	NULL
were	NULL
used	NULL
in	NULL
transient	NULL
transfection	NULL
assays	NULL
to	NULL
identify	NULL
promoter	NULL
elements	NULL
required	NULL
for	NULL
basal	NULL
and	NULL
inducible	NULL
gene	NULL
expression	NULL
.	NULL

A	NULL
PMA	NULL
responsive	NULL
element	NULL
was	NULL
localized	NULL
to	NULL
a	NULL
region	NULL
between	NULL
-319	NULL
and	NULL
-219	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
initiation	NULL
codon	NULL
and	NULL
co-trans-fections	NULL
with	NULL
transcription	NULL
factor	NULL
expression	NULL
plasmids	NULL
for	NULL
AP-2	NULL
and	NULL
Sp1	NULL
resulted	NULL
in	NULL
augmented	NULL
ASM	NULL
promoter	NULL
activity	NULL
,	NULL
which	NULL
was	NULL
abolished	NULL
when	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
these	NULL
two	NULL
factors	NULL
were	NULL
deleted	NULL
.	NULL

Using	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
and	NULL
supershift	NULL
assays	NULL
we	NULL
demonstrate	NULL
that	NULL
this	NULL
region	NULL
is	NULL
specifically	NULL
bound	NULL
by	NULL
Spl	NULL
and	NULL
AP-2	NULL
.	NULL

These	NULL
factors	NULL
are	NULL
present	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
both	NULL
induced	NULL
and	NULL
uninduced	NULL
THP-1	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
complex	NULL
formed	NULL
appeared	NULL
to	NULL
increase	NULL
when	NULL
nuclear	NULL
extracts	NULL
from	NULL
PMAtreated	NULL
cells	NULL
were	NULL
used.8§	NULL
From	NULL
these	NULL
studies	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
a	NULL
concerted	NULL
action	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
AP-2	NULL
and	NULL
Sp1	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
up-regulation	NULL
of	NULL
ASM	NULL
expression	NULL
during	NULL
the	NULL
process	NULL
of	NULL
macrophage	NULL
differentia-tion.-Langmann	NULL
,	NULL
T.	NULL
,	NULL
C.	NULL
Buechler	NULL
,	NULL
S.	NULL
Ries	NULL
,	NULL
A.	NULL
Schaeffler	NULL
,	NULL
C.	NULL
Aslanidis	NULL
,	NULL
M.	NULL
Schuierer	NULL
,	NULL
M.	NULL
Weiler	NULL
,	NULL
K.	NULL
Sandhoff	NULL
,	NULL
P.	NULL
J.	NULL
de	NULL
Jong	NULL
,	NULL
and	NULL
G.	NULL
Schmitz	NULL
.	NULL

Transcription	NULL
factors	NULL
Sp1	NULL
and	NULL
AP-2	NULL
mediate	NULL
induction	NULL
of	NULL
acid	NULL
sphingomyelinase	NULL
during	NULL
monocytic	NULL
differentiation	NULL
.	NULL

J.	NULL
Lipid	NULL
Res	NULL
.	NULL

1999	NULL
.	NULL

40	NULL
:	NULL
870-880	NULL
.	NULL

Supplementary	NULL
key	NULL
words	NULL
-	NULL
acid	NULL
sphingomyelinase	NULL
»	NULL
gene	NULL
regulation	NULL
®	NULL
monocyte	NULL
«	NULL
macrophage	NULL
«	NULL
differentiation	NULL
«	NULL
ASM-promoter	NULL
«	NULL
transcription	NULL
factors	NULL
870	NULL
Journal	NULL
of	NULL
Lipid	NULL
Research	NULL
Volume	NULL
40	NULL
,	NULL
1999	NULL
Human	NULL
acid	NULL
sphingomyelinase	NULL
is	NULL
a	NULL
lysosomal	NULL
hydrolase	NULL
required	NULL
for	NULL
the	NULL
cleavage	NULL
of	NULL
sphingomyelin	NULL
to	NULL
phospho-choline	NULL
and	NULL
ceramide	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
enzyme	NULL
with	NULL
a	NULL
pH	NULL
optimum	NULL
of	NULL
4.5	NULL
and	NULL
a	NULL
molecular	NULL
mass	NULL
of	NULL
72	NULL
kDa	NULL
was	NULL
purified	NULL
from	NULL
human	NULL
urine	NULL
by	NULL
Quintern	NULL
et	NULL
al	NULL
.	NULL

(	NULL
2	NULL
)	NULL
.	NULL

ASM	NULL
deficiency	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
autosomal	NULL
recessive	NULL
sphingomyelin	NULL
storage	NULL
disorders	NULL
Niemann-Pick	NULL
disease	NULL
type	NULL
A	NULL
(	NULL
NPD-A	NULL
)	NULL
and	NULL
type	NULL
B	NULL
(	NULL
NPD-B	NULL
)	NULL
.	NULL

These	NULL
two	NULL
forms	NULL
are	NULL
distinguished	NULL
by	NULL
well-defined	NULL
clinical	NULL
symptoms	NULL
.	NULL

NPD-A	NULL
patients	NULL
show	NULL
severe	NULL
neurodegenerative	NULL
lesions	NULL
and	NULL
die	NULL
within	NULL
the	NULL
first	NULL
2	NULL
years	NULL
of	NULL
life	NULL
,	NULL
while	NULL
in	NULL
NPD-B	NULL
patients	NULL
who	NULL
have	NULL
a	NULL
prolonged	NULL
lifespan	NULL
beyond	NULL
middle	NULL
age	NULL
,	NULL
only	NULL
the	NULL
organs	NULL
of	NULL
the	NULL
reticuloendothelial	NULL
system	NULL
are	NULL
affected	NULL
and	NULL
minimal	NULL
neurologic	NULL
in	NULL
volvement	NULL
occurs	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

A	NULL
valuable	NULL
animal	NULL
model	NULL
for	NULL
NPD-A	NULL
has	NULL
been	NULL
generated	NULL
recently	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
,	NULL
with	NULL
a	NULL
phenotype	NULL
similar	NULL
to	NULL
the	NULL
human	NULL
disease	NULL
that	NULL
is	NULL
currently	NULL
used	NULL
for	NULL
the	NULL
evaluation	NULL
of	NULL
various	NULL
therapeutic	NULL
regimens	NULL
.	NULL

Beyond	NULL
its	NULL
catalytic	NULL
lysosomal	NULL
function	NULL
,	NULL
ASM	NULL
is	NULL
discussed	NULL
to	NULL
contribute	NULL
in	NULL
cytokine	NULL
signalling	NULL
pathways	NULL
by	NULL
releasing	NULL
ceramide	NULL
,	NULL
as	NULL
a	NULL
second	NULL
messenger	NULL
from	NULL
sphingomyelin	NULL
(	NULL
7-10	NULL
)	NULL
.	NULL

Three	NULL
distinct	NULL
ASM	NULL
transcripts	NULL
resulting	NULL
from	NULL
alternative	NULL
splicing	NULL
were	NULL
isolated	NULL
and	NULL
expressed	NULL
in	NULL
COS-1	NULL
cells	NULL
,	NULL
demonstrating	NULL
that	NULL
only	NULL
the	NULL
full-length	NULL
mRNA	NULL
form	NULL
encoded	NULL
a	NULL
catalytically	NULL
active	NULL
enzyme	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
gene	NULL
is	NULL
5kb	NULL
in	NULL
length	NULL
,	NULL
consists	NULL
of	NULL
six	NULL
exons	NULL
,	NULL
and	NULL
maps	NULL
to	NULL
chromosome	NULL
11p15.1-11p15.4	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

The	NULL
putative	NULL
promoter	NULL
region	NULL
has	NULL
been	NULL
cloned	NULL
,	NULL
however	NULL
,	NULL
no	NULL
detailed	NULL
characterization	NULL
of	NULL
promoter	NULL
elements	NULL
has	NULL
been	NULL
reported	NULL
so	NULL
far	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Abbreviations	NULL
:	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate-l3-acetate	NULL
;	NULL
ASM	NULL
,	NULL
acid	NULL
sphingomyelinase	NULL
;	NULL
NPD	NULL
,	NULL
Niemann-Pick	NULL
disease	NULL
;	NULL
MCSF	NULL
,	NULL
macrophage-colony	NULL
stimulating	NULL
factor	NULL
;	NULL
PAC	NULL
,	NULL
P1	NULL
artificial	NULL
chromosome	NULL
;	NULL
SR-A	NULL
,	NULL
scavenger	NULL
receptor	NULL
type	NULL
A	NULL
;	NULL
GAPDH	NULL
,	NULL
glyceraledehyde3-phosphate	NULL
dehydroge-nase	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
Sp1	NULL
,	NULL
specificity	NULL
protein	NULL
1	NULL
;	NULL
AP2	NULL
,	NULL
activator	NULL
protein	NULL
2	NULL
;	NULL
SIF	NULL
,	NULL
shift	NULL
fragment	NULL
.	NULL

*	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL
ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
ASM	NULL
obviously	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
in	NULL
phagocytic	NULL
tissue	NULL
macrophages	NULL
as	NULL
is	NULL
reflected	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
large	NULL
lysosomal	NULL
compartement	NULL
for	NULL
intracellular	NULL
digestive	NULL
pro-cesses	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
ASM	NULL
can	NULL
be	NULL
secreted	NULL
by	NULL
various	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
macrophages	NULL
(	NULL
15	NULL
)	NULL
,	NULL
hydrolyze	NULL
atherogenic	NULL
lipoproteins	NULL
,	NULL
and	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
development	NULL
of	NULL
atherosclerotic	NULL
lesions	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

However	NULL
,	NULL
no	NULL
data	NULL
on	NULL
the	NULL
ASM	NULL
expression	NULL
in	NULL
monocytic	NULL
development	NULL
are	NULL
currently	NULL
available	NULL
.	NULL

Therefore	NULL
we	NULL
became	NULL
interested	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
ASM	NULL
during	NULL
monocyte	NULL
to	NULL
macrophage	NULL
maturation	NULL
and	NULL
in	NULL
the	NULL
more	NULL
immature	NULL
monocytic	NULL
cell	NULL
line	NULL
THP-1	NULL
.	NULL

This	NULL
cell	NULL
line	NULL
is	NULL
considered	NULL
as	NULL
an	NULL
excellent	NULL
,	NULL
legitimate	NULL
in	NULL
vitro	NULL
model	NULL
system	NULL
for	NULL
the	NULL
analysis	NULL
of	NULL
processes	NULL
related	NULL
to	NULL
monocytic	NULL
differentiation	NULL
due	NULL
to	NULL
its	NULL
simple	NULL
conversion	NULL
to	NULL
mature	NULL
macrophages	NULL
upon	NULL
phorbol	NULL
ester	NULL
stimulation	NULL
in	NULL
cell	NULL
culture	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
present	NULL
study	NULL
demonstrates	NULL
that	NULL
monocytic	NULL
differentiation	NULL
induces	NULL
ASM	NULL
mRNA	NULL
expression	NULL
mainly	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
identified	NULL
DNA	NULL
sequence	NULL
elements	NULL
and	NULL
their	NULL
corresponding	NULL
transcription	NULL
factors	NULL
that	NULL
are	NULL
required	NULL
for	NULL
the	NULL
PMA-mediated	NULL
induction	NULL
of	NULL
the	NULL
ASM	NULL
promoter	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
the	NULL
cis-elements	NULL
necessary	NULL
for	NULL
basal	NULL
and	NULL
differentiation	NULL
induced	NULL
promoter	NULL
activity	NULL
,	NULL
we	NULL
used	NULL
5	NULL
'	NULL
truncations	NULL
and	NULL
mutagenized	NULL
fragments	NULL
of	NULL
the	NULL
ASM	NULL
gene	NULL
fused	NULL
to	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

With	NULL
these	NULL
constructs	NULL
we	NULL
were	NULL
able	NULL
to	NULL
define	NULL
PMA-responsive	NULL
elements	NULL
.	NULL

Binding	NULL
of	NULL
transcription	NULL
factors	NULL
to	NULL
specific	NULL
promoter	NULL
sites	NULL
has	NULL
been	NULL
demonstrated	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
and	NULL
DNaseI	NULL
footprinting	NULL
experiments	NULL
.	NULL

Our	NULL
studies	NULL
clearly	NULL
demonstrate	NULL
the	NULL
engagement	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
Spl	NULL
and	NULL
AP-2	NULL
in	NULL
the	NULL
transcriptional	NULL
induction	NULL
of	NULL
the	NULL
acid	NULL
sphingomyelinase	NULL
gene	NULL
observed	NULL
during	NULL
monocyte	NULL
to	NULL
macrophage	NULL
differentiation	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Isolation	NULL
and	NULL
culture	NULL
of	NULL
cells	NULL
Peripheral	NULL
blood	NULL
monocytes	NULL
were	NULL
isolated	NULL
by	NULL
leukapheresis	NULL
and	NULL
counterflow	NULL
elutriation	NULL
(	NULL
19	NULL
)	NULL
.	NULL

To	NULL
obtain	NULL
fractions	NULL
containing	NULL
>	NULL
90	NULL
%	NULL
CD14	NULL
positive	NULL
mononuclear	NULL
phagocytes	NULL
,	NULL
cells	NULL
were	NULL
pooled	NULL
and	NULL
cultured	NULL
on	NULL
plastic	NULL
Petri	NULL
dishes	NULL
in	NULL
macrophage	NULL
SFM	NULL
medium	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
containing	NULL
25	NULL
U/ml	NULL
recombinant	NULL
human	NULL
M-CSE	NULL
THP-1	NULL
cells	NULL
(	NULL
20	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
ATCC	NULL
,	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Sigma	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
,	NULL
100	NULL
U	NULL
penicillin	NULL
per	NULL
ml	NULL
,	NULL
100	NULL
ug	NULL
of	NULL
streptomycin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
incubated	NULL
in	NULL
10	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
air	NULL
at	NULL
37°C	NULL
.	NULL

To	NULL
induce	NULL
monocyte	NULL
to	NULL
macrophage	NULL
differentiation	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
160	NULL
nm	NULL
PMA	NULL
.	NULL

Isolation	NULL
of	NULL
human	NULL
genomic	NULL
clones	NULL
for	NULL
the	NULL
acid	NULL
sphingomyelinase	NULL
gene	NULL
and	NULL
reporter	NULL
gene	NULL
construction	NULL
A	NULL
human	NULL
genomic	NULL
PAC	NULL
library	NULL
in	NULL
pCYPAC-1	NULL
(	NULL
21	NULL
)	NULL
was	NULL
screened	NULL
with	NULL
a	NULL
[	NULL
a22P	NULL
]	NULL
dCTP	NULL
-labeled	NULL
probe	NULL
encompassing	NULL
nt	NULL
-203	NULL
to	NULL
+44	NULL
of	NULL
the	NULL
ASM	NULL
gene	NULL
with	NULL
+1	NULL
referring	NULL
to	NULL
the	NULL
initiation	NULL
codon	NULL
.	NULL

The	NULL
probe	NULL
was	NULL
generated	NULL
in	NULL
a	NULL
genomic	NULL
PCR	NULL
reaction	NULL
using	NULL
primers	NULL
ASM-203	NULL
(	NULL
5-GCCCGCCACCGAGAGATCAGCTGTC-3	NULL
'	NULL
)	NULL
and	NULL
ASM	NULL
+44	NULL
(	NULL
5	NULL
!	NULL

GACCTGGGGCAGCTCTGGCGGAGTGACGCT-3	NULL
'	NULL
)	NULL
.	NULL

To	NULL
generate	NULL
a	NULL
series	NULL
of	NULL
5	NULL
'	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
ASM	NULL
pro-moter	NULL
,	NULL
DNA	NULL
from	NULL
positive	NULL
PAC	NULL
clones	NULL
was	NULL
used	NULL
as	NULL
template	NULL
in	NULL
a	NULL
modified	NULL
PCR	NULL
reaction	NULL
using	NULL
7-deaza-2'-deoxyguanosine	NULL
(	NULL
c'dGTP	NULL
)	NULL
(	NULL
22	NULL
)	NULL
.	NULL

A	NULL
Xhol	NULL
restriction	NULL
site	NULL
was	NULL
created	NULL
in	NULL
the	NULL
upstream	NULL
and	NULL
a	NULL
HindIII	NULL
restriction	NULL
site	NULL
in	NULL
the	NULL
downstream	NULL
primers	NULL
used	NULL
in	NULL
the	NULL
PCR	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
upstream	NULL
oligonucleotides	NULL
used	NULL
for	NULL
generating	NULL
the	NULL
various	NULL
constructs	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
p	NULL
(	NULL
-519/	NULL
+112	NULL
)	NULL
Lue	NULL
,	NULL
5-CCCCTCGAGATCTGCCGCCTGCTCTCTCTACC	NULL
TCCC-3	NULL
'	NULL
;	NULL
p	NULL
(	NULL
-419/	NULL
+112	NULL
)	NULL
Lue	NULL
,	NULL
5'-CCCCTCTGAGGTCITTCCAC	NULL
CGACCACATCACATG-3	NULL
'	NULL
;	NULL
p	NULL
(	NULL
-319/	NULL
+112	NULL
)	NULL
Luc	NULL
,	NULL
5-CCCCTCGAG	NULL
CCCACCCCCGCAGCCCGTGCGCCC-3	NULL
'	NULL
;	NULL
p	NULL
(	NULL
-219/	NULL
+112	NULL
)	NULL
Luc	NULL
,	NULL
5'-CCCCTCGAGCGCAGCGTTGACAGCCGCCCGCCACC3	NULL
'	NULL
;	NULL
p	NULL
(	NULL
-119	NULL
+112	NULL
)	NULL
Lue	NULL
,	NULL
5'-CCCCTCGAGCCGACTACAGAGAAGGGTAATCG	NULL
GG-3	NULL
'	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
downstream	NULL
oligonucleotide	NULL
used	NULL
for	NULL
the	NULL
above	NULL
constructs	NULL
was	NULL
5-CCCAAGCTTCCAGCGGCCAGG	NULL
CCCATCCAAAGG-3	NULL
'	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
were	NULL
incubated	NULL
with	NULL
Xhol	NULL
and	NULL
HindIII	NULL
restriction	NULL
enzymes	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
Xhol/	NULL
HindIII	NULL
site	NULL
of	NULL
the	NULL
pGL3-basic	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Mutations	NULL
in	NULL
the	NULL
AP-2	NULL
site	NULL
at	NULL
-289	NULL
and	NULL
in	NULL
the	NULL
Spl	NULL
site	NULL
at	NULL
-279	NULL
were	NULL
generated	NULL
using	NULL
oligonucleotides	NULL
with	NULL
base	NULL
substitutions	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
subcloned	NULL
DNA	NULL
fragments	NULL
was	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

DNA	NULL
transfection	NULL
experiments	NULL
THP-1	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
procedure	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
with	NULL
minor	NULL
modifications	NULL
.	NULL

Cells	NULL
(	NULL
2	NULL
%	NULL
10	NULL
``	NULL
)	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
with	NULL
5	NULL
ml	NULL
of	NULL
TS	NULL
(	NULL
25	NULL
mm	NULL
Tris/	NULL
HCJ	NULL
,	NULL
pH7.4	NULL
;	NULL
5	NULL
mm	NULL
KC	NULL
]	NULL
;	NULL
0.7	NULL
mm	NULL
CaC	NULL
)	NULL
;	NULL
;	NULL
137	NULL
mm	NULL
NaCl	NULL
;	NULL
0.6	NULL
mm	NULL
Na	NULL
,	NULL
HPO4	NULL
;	NULL
0.5	NULL
mm	NULL
MgC	NULL
)	NULL
;	NULL
)	NULL
and	NULL
incubated	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
TS	NULL
containing	NULL
10	NULL
ug	NULL
of	NULL
supercoiled	NULL
plasmid	NULL
DNA	NULL
and	NULL
50	NULL
pg/ml	NULL
of	NULL
DEAE-dextran	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
100	NULL
um	NULL
chlo-roquin	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
,	NULL
resuspended	NULL
in	NULL
complete	NULL
medium	NULL
,	NULL
and	NULL
cultivated	NULL
for	NULL
46	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
PMA	NULL
.	NULL

In	NULL
cotransfection	NULL
experiments	NULL
,	NULL
50	NULL
ng	NULL
of	NULL
transcription	NULL
factor	NULL
expression	NULL
plasmid	NULL
or	NULL
pCMV	NULL
plasmid	NULL
as	NULL
negative	NULL
control	NULL
was	NULL
used	NULL
.	NULL

In	NULL
each	NULL
set	NULL
,	NULL
pGL3-basic	NULL
and	NULL
pGL3-promoter	NULL
plasmids	NULL
served	NULL
as	NULL
negative	NULL
and	NULL
positive	NULL
controls	NULL
,	NULL
respectively	NULL
Two	NULL
jug	NULL
of	NULL
pSVB-galactosidase	NULL
plasmid	NULL
(	NULL
Promega	NULL
)	NULL
was	NULL
included	NULL
in	NULL
all	NULL
assays	NULL
to	NULL
gauge	NULL
transfection	NULL
efficiencies	NULL
.	NULL

Luciferase	NULL
assays	NULL
Transfected	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
washed	NULL
once	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
500	NULL
wl	NULL
of	NULL
reporter	NULL
lysis	NULL
buffer	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

After	NULL
pelleting	NULL
of	NULL
cellular	NULL
debris	NULL
in	NULL
a	NULL
microfuge	NULL
,	NULL
20	NULL
pl	NULL
of	NULL
cell	NULL
lysate	NULL
was	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
with	NULL
100	NULL
pl	NULL
luciferase	NULL
assay	NULL
reagent	NULL
(	NULL
Promega	NULL
)	NULL
in	NULL
a	NULL
Lumat	NULL
LB9501	NULL
(	NULL
Berthold	NULL
)	NULL
.	NULL

B-Galactosidase	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
standard	NULL
color	NULL
reaction	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Transcription	NULL
factor	NULL
expression	NULL
plasmids	NULL
The	NULL
transcription	NULL
factor	NULL
expression	NULL
plasmids	NULL
for	NULL
Spl	NULL
(	NULL
pPacS§pl	NULL
)	NULL
driven	NULL
by	NULL
the	NULL
actin	NULL
promoter	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
R.	NULL
Tjian	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
Berkeley	NULL
.	NULL

Plasmids	NULL
for	NULL
AP2	NULL
«	NULL
(	NULL
pCMVAP-2	NULL
«	NULL
)	NULL
,	NULL
Myc	NULL
(	NULL
pCMVMyc	NULL
)	NULL
,	NULL
and	NULL
BTEB	NULL
(	NULL
pCMVBTEB	NULL
)	NULL
driven	NULL
by	NULL
the	NULL
CMV	NULL
promoter	NULL
were	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
R.	NULL
Buettner	NULL
,	NULL
Institute	NULL
for	NULL
Pathology	NULL
,	NULL
University	NULL
of	NULL
Regensburg	NULL
.	NULL

Isolation	NULL
of	NULL
RNA	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
the	NULL
guanidinium	NULL
isothiocy-anate-cesium	NULL
chloride	NULL
technique	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Ten	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
electrophoresed	NULL
through	NULL
a	NULL
1.2	NULL
%	NULL
agarose	NULL
gel	NULL
containing	NULL
6	NULL
%	NULL
formaldehyde	NULL
and	NULL
blotted	NULL
onto	NULL
nylon	NULL
membranes	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
)	NULL
.	NULL

After	NULL
crosslinking	NULL
with	NULL
U	NULL
Virradiation	NULL
(	NULL
Stratalinker	NULL
model	NULL
1800	NULL
,	NULL
Stratagene	NULL
)	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
hybridized	NULL
with	NULL
cDNA	NULL
probe	NULL
P3/	NULL
P4	NULL
spanning	NULL
nt	NULL
950	NULL
to	NULL
1330	NULL
of	NULL
the	NULL
ASM	NULL
cDNA	NULL
(	NULL
11	NULL
)	NULL
,	NULL
stripped	NULL
,	NULL
and	NULL
subsequently	NULL
hybridized	NULL
with	NULL
a	NULL
human	NULL
B-actin	NULL
probe	NULL
.	NULL

The	NULL
probes	NULL
were	NULL
radiolabeled	NULL
with	NULL
[	NULL
@	NULL
``	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
using	NULL
the	NULL
Oli-golabeling	NULL
kit	NULL
from	NULL
Pharmacia	NULL
.	NULL

Hybridization	NULL
and	NULL
washing	NULL
con	NULL
Langmann	NULL
e	NULL
al	NULL
.	NULL

-	NULL
Spl	NULL
and	NULL
AP-2	NULL
mediate	NULL
sphingomyelinase	NULL
induction	NULL
in	NULL
monocytes	NULL
871	NULL
6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL
ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
ditions	NULL
were	NULL
performed	NULL
as	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
of	NULL
the	NULL
membrane	NULL
.	NULL

Nuclear	NULL
run-on	NULL
transcription	NULL
assay	NULL
Intact	NULL
nuclei	NULL
were	NULL
isolated	NULL
from	NULL
untreated	NULL
or	NULL
PMA-treated	NULL
(	NULL
160	NULL
nm	NULL
for	NULL
24	NULL
h	NULL
)	NULL
THP-1	NULL
cells	NULL
and	NULL
subjected	NULL
to	NULL
nuclear	NULL
run-on	NULL
transcription	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Radiolabeled	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
the	NULL
RNAzol	NULL
method	NULL
(	NULL
Biogentex	NULL
,	NULL
Houston	NULL
TX	NULL
)	NULL
.	NULL

The	NULL
P3/	NULL
P4	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
ASM	NULL
cDNA	NULL
,	NULL
a	NULL
GAPDH	NULL
gene	NULL
frag-ment	NULL
,	NULL
and	NULL
a	NULL
scavenger	NULL
receptor	NULL
type	NULL
A	NULL
cDNA	NULL
fragment	NULL
were	NULL
subcloned	NULL
into	NULL
pUC18	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

Ten	NULL
pg	NULL
of	NULL
these	NULL
plasmids	NULL
was	NULL
linearized	NULL
with	NULL
appropriate	NULL
restriction	NULL
enzymes	NULL
,	NULL
alkaline	NULL
dena-tured	NULL
,	NULL
and	NULL
blotted	NULL
onto	NULL
nylon	NULL
membranes	NULL
using	NULL
a	NULL
slotted	NULL
filtration	NULL
manifold	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
)	NULL
.	NULL

Hybridization	NULL
and	NULL
washing	NULL
of	NULL
the	NULL
membrane	NULL
strips	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Srivastava	NULL
,	NULL
Cable	NULL
,	NULL
and	NULL
Bonkovsky	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Ribonuclease	NULL
protection	NULL
assay	NULL
A	NULL
333	NULL
bp	NULL
BamHI-Sacl	NULL
restriction	NULL
fragment	NULL
from	NULL
the	NULL
ASM	NULL
cDNA	NULL
was	NULL
used	NULL
to	NULL
discriminate	NULL
between	NULL
type	NULL
1	NULL
and	NULL
type	NULL
2	NULL
transcripts	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
fragment	NULL
was	NULL
subcloned	NULL
into	NULL
a	NULL
pGEM4Z	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

To	NULL
generate	NULL
a	NULL
*P	NULL
labeled	NULL
riboprobe	NULL
,	NULL
the	NULL
plasmid	NULL
was	NULL
linearized	NULL
and	NULL
in	NULL
vitro	NULL
transcribed	NULL
using	NULL
[	NULL
«	NULL
22P	NULL
]	NULL
CTP	NULL
and	NULL
SP6	NULL
RNA	NULL
polymerase	NULL
.	NULL

Nuclease	NULL
protection	NULL
assay	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
RNase	NULL
Protection	NULL
kit	NULL
(	NULL
Boehringer	NULL
)	NULL
.	NULL

Ten	NULL
jug	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
untreated	NULL
or	NULL
PMA-induced	NULL
THP-1	NULL
cells	NULL
was	NULL
hybridized	NULL
with	NULL
the	NULL
radiolabeled	NULL
riboprobe	NULL
.	NULL

After	NULL
RNase	NULL
treatment	NULL
,	NULL
protected	NULL
fragments	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
8	NULL
%	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
fixed	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
exposed	NULL
to	NULL
film	NULL
.	NULL

DNaseI	NULL
footprinting	NULL
A	NULL
genomic	NULL
DNA	NULL
fragment	NULL
spanning	NULL
from	NULL
-368	NULL
to	NULL
-252	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
start	NULL
of	NULL
translation	NULL
was	NULL
radiolabeled	NULL
at	NULL
one	NULL
end	NULL
with	NULL
dCTP	NULL
and	NULL
Klenow	NULL
DNA	NULL
polymerase	NULL
.	NULL

The	NULL
probe	NULL
was	NULL
purified	NULL
using	NULL
Microspin	NULL
S-200	NULL
HR	NULL
columns	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
site	NULL
for	NULL
Sp1	NULL
was	NULL
detected	NULL
using	NULL
the	NULL
SureTrack	NULL
Footprinting	NULL
kit	NULL
(	NULL
Pharmacia	NULL
)	NULL
and	NULL
purified	NULL
Spl	NULL
protein	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
and	NULL
DNaselI	NULL
digestion	NULL
were	NULL
performed	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

The	NULL
resulting	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
8	NULL
%	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

For	NULL
a	NULL
sequence	NULL
ladder	NULL
,	NULL
the	NULL
same	NULL
probe	NULL
fragment	NULL
was	NULL
partially	NULL
cleaved	NULL
at	NULL
guanine	NULL
and	NULL
adenosine	NULL
residues	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Maxam	NULL
and	NULL
Gilbert	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
THP-1	NULL
cells	NULL
(	NULL
50	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
harvested	NULL
by	NULL
centrifugation	NULL
,	NULL
washed	NULL
once	NULL
with	NULL
ice-cold	NULL
PBS	NULL
,	NULL
and	NULL
washed	NULL
twice	NULL
with	NULL
wash	NULL
buffer	NULL
composed	NULL
of	NULL
10	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
1.5	NULL
mm	NULL
MgC	NULL
)	NULL
,	NULL
10	NULL
mm	NULL
KCl	NULL
,	NULL
0.5	NULL
mx	NULL
dithiothreitol	NULL
(	NULL
DTT	NULL
)	NULL
,	NULL
and	NULL
0.5	NULL
mm	NULL
phenylmethylsul-fonyl	NULL
fluoride	NULL
(	NULL
PMSF	NULL
)	NULL
.	NULL

After	NULL
resuspension	NULL
in	NULL
1	NULL
ml	NULL
ice-cold	NULL
wash	NULL
buffer	NULL
,	NULL
cells	NULL
were	NULL
centrifuged	NULL
1	NULL
min	NULL
at	NULL
full	NULL
speed	NULL
in	NULL
a	NULL
microfuge	NULL
.	NULL

Hypotonic	NULL
buffer	NULL
containing	NULL
0.1	NULL
%	NULL
NP4O0	NULL
was	NULL
added	NULL
to	NULL
lyse	NULL
the	NULL
cell	NULL
pellet	NULL
.	NULL

After	NULL
5	NULL
min	NULL
incubation	NULL
on	NULL
ice	NULL
,	NULL
nuclei	NULL
were	NULL
pelleted	NULL
in	NULL
a	NULL
microfuge	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
lysis	NULL
buffer	NULL
containing	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
0.42	NULL
m	NULL
NaCl	NULL
,	NULL
1.5	NULL
mm	NULL
MgC	NULL
)	NULL
;	NULL
,	NULL
0.2	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
mm	NULL
DTT	NULL
,	NULL
0.5	NULL
mm	NULL
PMSF	NULL
,	NULL
and	NULL
10	NULL
%	NULL
wv	NULL
glycerol	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
4°C	NULL
for	NULL
15	NULL
min	NULL
with	NULL
gentle	NULL
vortexing	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
nuclear	NULL
debris	NULL
was	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
at	NULL
4°C	NULL
for	NULL
15	NULL
min	NULL
and	NULL
the	NULL
supernatant	NULL
was	NULL
diluted	NULL
1:6	NULL
with	NULL
storage	NULL
buffer	NULL
composed	NULL
of	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
0.05	NULL
m	NULL
KCI	NULL
,	NULL
0.2	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
muDTT	NULL
,	NULL
0.5	NULL
mu	NULL
PMSE	NULL
and	NULL
20	NULL
%	NULL
w	NULL
v	NULL
glycerol	NULL
.	NULL

The	NULL
extracts	NULL
were	NULL
aliquoted	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

Protein	NULL
concentration	NULL
of	NULL
an	NULL
aliquot	NULL
was	NULL
determined	NULL
using	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
reagent	NULL
.	NULL

The	NULL
integrity	NULL
of	NULL
the	NULL
nuclear	NULL
extract	NULL
preparations	NULL
was	NULL
assessed	NULL
by	NULL
determining	NULL
the	NULL
ability	NULL
of	NULL
proteins	NULL
to	NULL
bind	NULL
to	NULL
a	NULL
radiolabeled	NULL
Oct-1	NULL
double-stranded	NULL
oligonucleotide	NULL
872	NULL
Journal	NULL
of	NULL
Lipid	NULL
Research	NULL
Volume	NULL
40	NULL
,	NULL
1999	NULL
GCAAATCACTAGAA3	NULL
'	NULL
)	NULL
.	NULL

Oct-l	NULL
binding	NULL
was	NULL
constitutive	NULL
and	NULL
thus	NULL
served	NULL
as	NULL
internal	NULL
control	NULL
.	NULL

Gel	NULL
mobility	NULL
shift	NULL
assay	NULL
Nuclear	NULL
extracts	NULL
(	NULL
10	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
or	NULL
purified	NULL
transcription	NULL
factors	NULL
(	NULL
1	NULL
footprinting	NULL
unit	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
2	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
)	NULL
in	NULL
20	NULL
pl	NULL
binding	NULL
buffer	NULL
containing	NULL
50	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
6	NULL
mm	NULL
MgC	NULL
)	NULL
,	NULL
50	NULL
mx	NULL
KCl	NULL
,	NULL
5	NULL
mm	NULL
DTT	NULL
,	NULL
100	NULL
pg/	NULL
ml	NULL
BSA	NULL
,	NULL
and	NULL
0.01	NULL
%	NULL
NP4O0	NULL
.	NULL

[	NULL
*P	NULL
]	NULL
end-labeled	NULL
probes	NULL
(	NULL
30,000	NULL
cpm	NULL
)	NULL
were	NULL
added	NULL
and	NULL
the	NULL
reaction	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

In	NULL
competition	NULL
experiments	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
preincubated	NULL
for	NULL
10	NULL
min	NULL
with	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
non-labeled	NULL
competitor	NULL
.	NULL

Supershift	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
antibodies	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
;	NULL
Sp1	NULL
,	NULL
catalog	NULL
number	NULL
sc-59x	NULL
,	NULL
rabbit	NULL
polyclonal	NULL
against	NULL
residues	NULL
436-454	NULL
of	NULL
human	NULL
Spl	NULL
;	NULL
AP2	NULL
«	NULL
,	NULL
catalog	NULL
number	NULL
sc-184x	NULL
,	NULL
rabbit	NULL
polyclonal	NULL
against	NULL
residues	NULL
420-437	NULL
of	NULL
human	NULL
AP2	NULL
«	NULL
;	NULL
Ets-1	NULL
,	NULL
catalog	NULL
number	NULL
sc-112x	NULL
,	NULL
rabbit	NULL
polyclonal	NULL
against	NULL
residues	NULL
362-364	NULL
of	NULL
human	NULL
Ets-1	NULL
;	NULL
PU.1	NULL
,	NULL
catalog	NULL
number	NULL
sc-352x	NULL
,	NULL
rabbit	NULL
polyclonal	NULL
against	NULL
residues	NULL
420-437	NULL
of	NULL
mouse	NULL
PU.1	NULL
.	NULL

The	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
8	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
at	NULL
80	NULL
V	NULL
using	NULL
0.25	NULL
X	NULL
TBE	NULL
(	NULL
25	NULL
)	NULL
as	NULL
electrophoresis	NULL
buffer	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
X-Omat	NULL
AR	NULL
films	NULL
overnight	NULL
at	NULL
-70°C	NULL
.	NULL

For	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
experiments	NULL
the	NULL
following	NULL
oligonucleotides	NULL
annealed	NULL
to	NULL
their	NULL
respective	NULL
complementary	NULL
oligonucleotides	NULL
have	NULL
been	NULL
used	NULL
:	NULL
SIF3	NULL
(	NULL
5'-AGCCCCGCAGCCCGTGCGCCCGGGGCAGGG	NULL
CGGGGGCAGGGA-3	NULL
'	NULL
)	NULL
;	NULL
SIF3MI	NULL
(	NULL
5-AGCCCCGCAGCCCGTGC	NULL
GAACGGAACAGGGCGGGGGCAGGGA-3	NULL
'	NULL
)	NULL
;	NULL
SIF4	NULL
GGGCGGAATCGGGGCGGTCCCGGGAGCGCCCCGCCC-3	NULL
'	NULL
)	NULL
;	NULL
SIF6	NULL
(	NULL
5-AGGATCAGCTGTCAGAGATCAGAGGAAGAGGA	NULL
AGGGGCGGAG-3	NULL
'	NULL
)	NULL
.	NULL

Electrophoresis	NULL
and	NULL
immunoblotting	NULL
SDS-polyacrylamide	NULL
gelelectrophoresis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Proteins	NULL
were	NULL
transferred	NULL
to	NULL
Immobilon	NULL
as	NULL
reported	NULL
.	NULL

Transfer	NULL
was	NULL
confirmed	NULL
by	NULL
Coomassie	NULL
Blue	NULL
staining	NULL
of	NULL
the	NULL
gel	NULL
after	NULL
the	NULL
electroblot	NULL
.	NULL

Polyclonal	NULL
affinity-purified	NULL
antibodies	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
against	NULL
Sp1	NULL
,	NULL
PU.1	NULL
,	NULL
and	NULL
c-Jun	NULL
were	NULL
used	NULL
at	NULL
a	NULL
5	NULL
ug/	NULL
ml	NULL
dilution	NULL
in	NULL
1	NULL
%	NULL
nonfat	NULL
dry	NULL
milk	NULL
,	NULL
0.02	NULL
%	NULL
sodium	NULL
azide	NULL
in	NULL
PBS	NULL
and	NULL
incubated	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

Detection	NULL
of	NULL
the	NULL
immune	NULL
complexes	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
the	NULL
ECL	NULL
Western	NULL
blot	NULL
detection	NULL
system	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
.	NULL

RESULTS	NULL
Changes	NULL
in	NULL
ASM	NULL
mRNA	NULL
expression	NULL
associated	NULL
with	NULL
monocytic	NULL
differentiation	NULL
Northern	NULL
analysis	NULL
was	NULL
used	NULL
to	NULL
quantitate	NULL
the	NULL
relative	NULL
amounts	NULL
of	NULL
ASM	NULL
mRNA	NULL
in	NULL
THP-1	NULL
cells	NULL
at	NULL
different	NULL
time	NULL
points	NULL
after	NULL
PMA	NULL
treatment	NULL
,	NULL
in	NULL
monocytes	NULL
and	NULL
in	NULL
monocyte-derived	NULL
macrophages	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

In	NULL
undifferentiated	NULL
THP-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
no	NULL
measureable	NULL
amount	NULL
of	NULL
ASM	NULL
mRNA	NULL
was	NULL
present	NULL
.	NULL

Steady-state	NULL
levels	NULL
of	NULL
the	NULL
ASM	NULL
message	NULL
increased	NULL
successively	NULL
after	NULL
PMA-induced	NULL
differentiation	NULL
,	NULL
reaching	NULL
maximum	NULL
levels	NULL
after	NULL
24	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lanes	NULL
2-6	NULL
)	NULL
.	NULL

To	NULL
compare	NULL
these	NULL
results	NULL
from	NULL
the	NULL
THP-1	NULL
cell	NULL
line	NULL
with	NULL
results	NULL
from	NULL
human	NULL
blood	NULL
monocytes	NULL
,	NULL
ASM	NULL
mRNA	NULL
abundance	NULL
in	NULL
total	NULL
RNA	NULL
from	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
(	NULL
Mo	NULL
)	NULL
and	NULL
from	NULL
monocyte-derived	NULL
macrophages	NULL
after	NULL
7	NULL
days	NULL
in	NULL
culture	NULL
(	NULL
7dMNP	NULL
)	NULL
were	NULL
analyzed	NULL
.	NULL

mRNA	NULL
levels	NULL
for	NULL
ASM	NULL
similarly	NULL
increased	NULL
during	NULL
the	NULL
differentiation	NULL
process	NULL
of	NULL
native	NULL
monocytes	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lanes	NULL
7	NULL
6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL
ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
THP-1	NULL
+	NULL
PMA	NULL
7d	NULL
Oh	NULL
3h	NULL
6h	NULL
9h	NULL
12h	NULL
24h	NULL
Mo	NULL
MNP	NULL
ASM	NULL
$	NULL
-Actin|	NULL
#	NULL
@	NULL
@	NULL
@	NULL
@	NULL
#	NULL
#	NULL
®	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

ASM	NULL
mRNA	NULL
is	NULL
induced	NULL
during	NULL
monocyte	NULL
to	NULL
macrophage	NULL
differentiation	NULL
.	NULL

Total	NULL
RNAs	NULL
were	NULL
isolated	NULL
from	NULL
THP-1	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
for	NULL
0	NULL
,	NULL
3	NULL
,	NULL
6	NULL
,	NULL
9	NULL
,	NULL
12	NULL
,	NULL
24	NULL
h	NULL
,	NULL
from	NULL
freshly	NULL
isolated	NULL
monocytes	NULL
(	NULL
Mo	NULL
)	NULL
and	NULL
from	NULL
monocyte-derived	NULL
macrophages	NULL
(	NULL
7dMNP	NULL
)	NULL
.	NULL

Each	NULL
lane	NULL
was	NULL
loaded	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
total	NULL
RNA	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
hybridized	NULL
with	NULL
the	NULL
P-labeled	NULL
ASM	NULL
cDNA	NULL
fragment	NULL
P3/	NULL
P4	NULL
.	NULL

The	NULL
lower	NULL
panel	NULL
displays	NULL
the	NULL
hybridization	NULL
analysis	NULL
of	NULL
the	NULL
same	NULL
blot	NULL
performed	NULL
with	NULL
a	NULL
human	NULL
B-actin	NULL
probe	NULL
as	NULL
control	NULL
.	NULL

8	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
these	NULL
results	NULL
on	NULL
the	NULL
level	NULL
of	NULL
protein	NULL
expres-sion	NULL
,	NULL
immunoblots	NULL
were	NULL
carried	NULL
out	NULL
and	NULL
were	NULL
found	NULL
to	NULL
produce	NULL
similar	NULL
results	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
type	NULL
1	NULL
and	NULL
type	NULL
2	NULL
ASM	NULL
transcripts	NULL
in	NULL
differentiating	NULL
THP	NULL
cells	NULL
RNase	NULL
protection	NULL
analysis	NULL
was	NULL
performed	NULL
to	NULL
determine	NULL
the	NULL
relative	NULL
levels	NULL
of	NULL
type	NULL
1	NULL
and	NULL
type	NULL
2	NULL
ASM	NULL
transcripts	NULL
in	NULL
total	NULL
RNA	NULL
of	NULL
THP	NULL
-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Hybridization	NULL
of	NULL
the	NULL
333bp	NULL
antisense	NULL
probe	NULL
(	NULL
12	NULL
)	NULL
with	NULL
the	NULL
ASM	NULL
mRNA	NULL
resulted	NULL
in	NULL
two	NULL
protected	NULL
fragments	NULL
of	NULL
333bp	NULL
and	NULL
266	NULL
bp	NULL
,	NULL
originating	NULL
from	NULL
the	NULL
type	NULL
1	NULL
and	NULL
type	NULL
2	NULL
ASM	NULL
transcripts	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
both	NULL
transcripts	NULL
was	NULL
up-regulated	NULL
during	NULL
the	NULL
monocytic	NULL
differentiation	NULL
process	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
,	NULL
with	NULL
type	NULL
2	NULL
transcripts	NULL
representing	NULL
only	NULL
a	NULL
minor	NULL
part	NULL
of	NULL
the	NULL
ASM	NULL
message	NULL
.	NULL

Measurement	NULL
of	NULL
ASM	NULL
transcription	NULL
rate	NULL
during	NULL
PMA-induced	NULL
differentiation	NULL
of	NULL
THP-1	NULL
cells	NULL
In	NULL
order	NULL
to	NULL
elucidate	NULL
whether	NULL
the	NULL
up-regulation	NULL
of	NULL
the	NULL
steady-state	NULL
level	NULL
of	NULL
ASM	NULL
mRNA	NULL
was	NULL
due	NULL
to	NULL
changes	NULL
in	NULL
the	NULL
rate	NULL
of	NULL
transcription	NULL
or	NULL
post-transcriptional	NULL
mechanisms	NULL
,	NULL
nuclear	NULL
run-on	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
nuclei	NULL
isolated	NULL
either	NULL
from	NULL
undifferentiated	NULL
cells	NULL
or	NULL
cells	NULL
treated	NULL
with	NULL
PMA	NULL
for	NULL
24	NULL
h.	NULL
Radiolabeled	NULL
transcripts	NULL
were	NULL
allowed	NULL
to	NULL
hybridize	NULL
to	NULL
cDNA	NULL
probes	NULL
for	NULL
ASM	NULL
,	NULL
scavenger	NULL
receptor	NULL
type	NULL
A	NULL
(	NULL
SR-A	NULL
)	NULL
,	NULL
and	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
or	NULL
the	NULL
insertless	NULL
pUC18	NULL
cloning	NULL
vector	NULL
on	NULL
nylon	NULL
membranes	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

The	NULL
transcriptional	NULL
induction	NULL
of	NULL
scavenger	NULL
receptor	NULL
type	NULL
A	NULL
after	NULL
stimulation	NULL
of	NULL
THP-1	NULL
cells	NULL
by	NULL
PMA	NULL
is	NULL
well	NULL
characterized	NULL
and	NULL
was	NULL
thus	NULL
used	NULL
as	NULL
positive	NULL
control	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

Our	NULL
experiments	NULL
clearly	NULL
demonstrate	NULL
that	NULL
the	NULL
increase	NULL
of	NULL
ASM	NULL
mRNA	NULL
amount	NULL
during	NULL
monocytic	NULL
differentiation	NULL
was	NULL
largely	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
.	NULL

The	NULL
transcription	NULL
rate	NULL
of	NULL
the	NULL
GAPDH	NULL
gene	NULL
was	NULL
up-regulated	NULL
to	NULL
a	NULL
much	NULL
lesser	NULL
extent	NULL
than	NULL
that	NULL
of	NULL
the	NULL
ASM	NULL
gene	NULL
after	NULL
PMA	NULL
induction	NULL
of	NULL
THP-1	NULL
cells	NULL
,	NULL
and	NULL
hybridization	NULL
to	NULL
the	NULL
pUC18	NULL
vector	NULL
produced	NULL
no	NULL
signal	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Simultaneous	NULL
incubation	NULL
of	NULL
THP-1	NULL
cells	NULL
with	NULL
A	NULL
THP-1	NULL
+	NULL
PMA	NULL
Oh	NULL
3h	NULL
6h	NULL
12h	NULL
24h	NULL
t	NULL
type	NULL
1-	NULL
»	NULL
«	NULL
g	NULL
»	NULL
.	NULL

type	NULL
2-	NULL
»	NULL
#	NULL
-PMA	NULL
+PMA	NULL
B	NULL
(	NULL
24h	NULL
)	NULL
<	NULL
-	NULL
ASM	NULL
<	NULL
-	NULL
ASM	NULL
<	NULL
-	NULL
SR-A	NULL
spsnmats	NULL
:	NULL
<	NULL
-	NULL
GAPDH	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

(	NULL
A	NULL
)	NULL
RNase	NULL
protection	NULL
analysis	NULL
of	NULL
ASM	NULL
transcripts	NULL
in	NULL
differentiating	NULL
THP-1	NULL
cells	NULL
.	NULL

The	NULL
333	NULL
bp	NULL
antisense	NULL
RNA	NULL
probe	NULL
was	NULL
designed	NULL
to	NULL
discriminate	NULL
between	NULL
type	NULL
1	NULL
and	NULL
type	NULL
2	NULL
ASM	NULL
transcripts	NULL
.	NULL

The	NULL
protected	NULL
fragments	NULL
for	NULL
type	NULL
1	NULL
and	NULL
type	NULL
2	NULL
transcripts	NULL
were	NULL
333	NULL
bp	NULL
and	NULL
266	NULL
bp	NULL
in	NULL
length	NULL
,	NULL
respectively	NULL
.	NULL

Lanes	NULL
1-5	NULL
contain	NULL
RNA	NULL
from	NULL
THP-1	NULL
cells	NULL
incubated	NULL
with	NULL
PMA	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
;	NULL
lane	NULL
t	NULL
,	NULL
mock	NULL
control	NULL
with	NULL
tRNA	NULL
;	NULL
lane	NULL
P	NULL
,	NULL
free	NULL
probe	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
type	NULL
1	NULL
and	NULL
type	NULL
2	NULL
protected	NULL
fragments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Induction	NULL
of	NULL
ASM	NULL
mRNA	NULL
depends	NULL
on	NULL
new	NULL
transcription	NULL
.	NULL

Nuclei	NULL
were	NULL
isolated	NULL
from	NULL
control	NULL
cells	NULL
(	NULL
-PMA	NULL
)	NULL
and	NULL
cells	NULL
treated	NULL
with	NULL
PMA	NULL
for	NULL
24	NULL
h	NULL
(	NULL
+PMA	NULL
)	NULL
.	NULL

Nascent	NULL
transcripts	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
a22P	NULL
]	NULL
UTP	NULL
and	NULL
hybridized	NULL
to	NULL
cDNA	NULL
probes	NULL
for	NULL
scavenger	NULL
receptor	NULL
type	NULL
A	NULL
(	NULL
SR-A	NULL
)	NULL
,	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
,	NULL
and	NULL
ASM	NULL
cDNA	NULL
fragment	NULL
P3/	NULL
P4	NULL
bound	NULL
to	NULL
nylon	NULL
membranes	NULL
.	NULL

actinomycin	NULL
D	NULL
and	NULL
PMA	NULL
did	NULL
not	NULL
result	NULL
in	NULL
enhanced	NULL
ASM	NULL
mRNA	NULL
levels	NULL
,	NULL
suggesting	NULL
that	NULL
ASM	NULL
mRNA	NULL
stability	NULL
is	NULL
not	NULL
prolonged	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

5'-Deletional	NULL
analysis	NULL
of	NULL
the	NULL
ASM	NULL
promoter	NULL
To	NULL
identify	NULL
sequences	NULL
important	NULL
for	NULL
promoter	NULL
activity	NULL
,	NULL
human	NULL
genomic	NULL
clones	NULL
containing	NULL
the	NULL
ASM	NULL
gene	NULL
were	NULL
isolated	NULL
by	NULL
screening	NULL
a	NULL
PAC	NULL
library	NULL
with	NULL
a	NULL
probe	NULL
encompassing	NULL
nt	NULL
-203	NULL
to	NULL
+44	NULL
of	NULL
the	NULL
ASM	NULL
gene	NULL
.	NULL

Five	NULL
promoter	NULL
constructs	NULL
with	NULL
successive	NULL
5	NULL
'	NULL
truncations	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
using	NULL
the	NULL
isolated	NULL
PAC	NULL
clones	NULL
as	NULL
template	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
the	NULL
deletions	NULL
ranged	NULL
from	NULL
-519	NULL
bp	NULL
to	NULL
-119	NULL
bp	NULL
proximal	NULL
to	NULL
the	NULL
initiation	NULL
codon	NULL
.	NULL

Two	NULL
minor	NULL
transcription	NULL
start	NULL
sites	NULL
at	NULL
nt	NULL
-251	NULL
and	NULL
nt	NULL
-117	NULL
and	NULL
one	NULL
major	NULL
transcription	NULL
start	NULL
site	NULL
at	NULL
nt	NULL
-160	NULL
have	NULL
been	NULL
identified	NULL
using	NULL
primer	NULL
extension	NULL
analysis	NULL
by	NULL
Newrzella	NULL
and	NULL
Stoffel	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
activities	NULL
of	NULL
the	NULL
constructs	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
.	NULL

The	NULL
promoterless	NULL
pGL3basic	NULL
vector	NULL
served	NULL
as	NULL
negative	NULL
control	NULL
and	NULL
displayed	NULL
no	NULL
promoter	NULL
activity	NULL
.	NULL

By	NULL
and	NULL
large	NULL
,	NULL
the	NULL
following	NULL
results	NULL
are	NULL
evident	NULL
from	NULL
Langmann	NULL
e	NULL
al	NULL
.	NULL

-	NULL
Spl	NULL
and	NULL
AP-2	NULL
mediate	NULL
sphingomyelinase	NULL
induction	NULL
in	NULL
monocytes	NULL
873	NULL
6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL
ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
A	NULL
Myc	NULL
CAE	NULL
CRE	NULL
AP-2§p1	NULL
Spt	NULL
Spt	NULL
PUA	NULL
PUA	NULL
Spt	NULL
AP2	NULL
-	NULL
+1	NULL
ATG	NULL
-391	NULL
+349	NULL
-329	NULL
-289	NULL
-279-2693	NULL
252	NULL
-169	NULL
161	NULL
155	NULL
79	NULL
p	NULL
(	NULL
-§19/+112	NULL
)	NULL
Luc	NULL
1	NULL
p	NULL
(	NULL
419/4+112	NULL
)	NULL
Lue	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
hr	NULL
:	NULL
Luciferase	NULL
p	NULL
(	NULL
-319/4¥112	NULL
)	NULL
Lue	NULL
-	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+o	NULL
>	NULL
f	NULL
V	NULL
‘	NULL
JI	NULL
Luciferase	NULL
|	NULL
P	NULL
(	NULL
219/4112	NULL
)	NULL
Lue	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
>	NULL
>	NULL
>	NULL
>	NULL
+	NULL
+	NULL
>	NULL
>	NULL
>	NULL
P	NULL
(	NULL
119/4112	NULL
)	NULL
Lue	NULL
2	NULL
L2	NULL
2	NULL
2	NULL
2	NULL
20.	NULL
;	NULL
B	NULL
250000	NULL
200000	NULL
150000	NULL
100000	NULL
=	NULL
relative	NULL
light	NULL
units	NULL
50000	NULL
7	NULL
pGL3	NULL
basic	NULL
g	NULL
p	NULL
(	NULL
-519/+112	NULL
)	NULL
Luc	NULL
WR	NULL
Control	NULL
COPMa	NULL
(	NULL
P	NULL
;	NULL
mils	NULL
_	NULL
(	NULL
1B	NULL
)	NULL
;	NULL
ww	NULL
,	NULL
.	NULL

:	NULL
o	NULL
O	NULL
o	NULL
3	NULL
3	NULL
3	NULL
<	NULL
5	NULL
)	NULL
_J	NULL
_	NULL
]	NULL
_	NULL
]	NULL
_	NULL
]	NULL
o	NULL
o	NULL
ou	NULL
ar	NULL
r-	NULL
y-	NULL
y	NULL
3	NULL
r-	NULL
T-	NULL
r-	NULL
T	NULL
+	NULL
+	NULL
+	NULL
+	NULL
~	NULL
p	NULL
~	NULL
=	NULL
.	NULL

o	NULL
o	NULL
o	NULL
0	NULL
v-	NULL
v-	NULL
r-	NULL
v-I	NULL
&	NULL
?	NULL

&	NULL
f	NULL
T	NULL
a.	NULL
G.	NULL
'	NULL
a	NULL
.	NULL

G.	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

(	NULL
A	NULL
)	NULL
ASM	NULL
promoter	NULL
region	NULL
with	NULL
putative	NULL
regulatory	NULL
elements	NULL
.	NULL

Putative	NULL
cis-acting	NULL
consensus	NULL
sequences	NULL
are	NULL
denoted	NULL
by	NULL
boxes	NULL
and	NULL
numbers	NULL
identify	NULL
their	NULL
positions	NULL
as	NULL
the	NULL
distance	NULL
to	NULL
the	NULL
ASM	NULL
start	NULL
codon	NULL
.	NULL

The	NULL
major	NULL
transcription	NULL
start	NULL
site	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
the	NULL
5'truncations	NULL
of	NULL
the	NULL
ASM	NULL
promoter	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
promoter	NULL
fragments	NULL
were	NULL
ligated	NULL
to	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
in	NULL
the	NULL
for	NULL
ward	NULL
orienta-tion	NULL
.	NULL

(	NULL
B	NULL
)	NULL
ASM	NULL
promoter	NULL
activity	NULL
lies	NULL
within	NULL
the	NULL
first	NULL
319	NULL
bp	NULL
of	NULL
the	NULL
5'-UTR	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
wg	NULL
of	NULL
each	NULL
reporter	NULL
gene	NULL
construct	NULL
,	NULL
or	NULL
the	NULL
promoterless	NULL
pGL3basic	NULL
vector	NULL
and	NULL
2	NULL
wg	NULL
of	NULL
pSVB-gal	NULL
plasmid	NULL
and	NULL
cultured	NULL
for	NULL
46	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
PMA	NULL
(	NULL
160	NULL
nm	NULL
)	NULL
,	NULL
at	NULL
which	NULL
time	NULL
cell	NULL
lysates	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

Assays	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
and	NULL
results	NULL
shown	NULL
are	NULL
normalized	NULL
to	NULL
the	NULL
B-galactosidase	NULL
expression	NULL
.	NULL

The	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
five	NULL
independent	NULL
experiments	NULL
.	NULL

Black	NULL
bars	NULL
show	NULL
basal	NULL
(	NULL
uninduced	NULL
)	NULL
activity	NULL
of	NULL
each	NULL
promoter	NULL
construct	NULL
and	NULL
grey	NULL
bars	NULL
indicate	NULL
PMA-induced	NULL
levels	NULL
of	NULL
activity	NULL
.	NULL

these	NULL
experiments	NULL
.	NULL
)	NULL

Similar	NULL
basal	NULL
promoter	NULL
activities	NULL
in	NULL
THP-1	NULL
cells	NULL
can	NULL
be	NULL
detected	NULL
with	NULL
constructs	NULL
p	NULL
(	NULL
-519/	NULL
+112	NULL
)	NULL
Luc	NULL
,	NULL
p	NULL
(	NULL
-419/	NULL
+112	NULL
)	NULL
Luc	NULL
,	NULL
and	NULL
p	NULL
(	NULL
-319/	NULL
+112	NULL
)	NULL
Luc	NULL
.	NULL

2	NULL
)	NULL
The	NULL
shorter	NULL
promoter	NULL
fragments	NULL
p	NULL
(	NULL
-219/	NULL
+112	NULL
)	NULL
Luc	NULL
and	NULL
p	NULL
(	NULL
-119/	NULL
+112	NULL
)	NULL
Luc	NULL
show	NULL
a	NULL
significant	NULL
decrease	NULL
of	NULL
basal	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
solid	NULL
bars	NULL
)	NULL
.	NULL

3	NULL
)	NULL
In	NULL
transfected	NULL
THP-1	NULL
cells	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
,	NULL
luciferase	NULL
activity	NULL
increased	NULL
between	NULL
2.7-	NULL
and	NULL
3.6	NULL
-fold	NULL
in	NULL
each	NULL
of	NULL
the	NULL
constructs	NULL
analyzed	NULL
,	NULL
except	NULL
for	NULL
the	NULL
two	NULL
shortest	NULL
fragments	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
grey	NULL
bars	NULL
)	NULL
.	NULL

These	NULL
promoter	NULL
activities	NULL
correlate	NULL
well	NULL
with	NULL
the	NULL
enhanced	NULL
transcription	NULL
found	NULL
in	NULL
the	NULL
nuclear	NULL
run	NULL
874	NULL
Journal	NULL
of	NULL
Lipid	NULL
Research	NULL
Volume	NULL
40	NULL
,	NULL
1999	NULL
on	NULL
analysis	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
assumed	NULL
that	NULL
the	NULL
response	NULL
elements	NULL
for	NULL
PMA	NULL
inducibility	NULL
are	NULL
located	NULL
within	NULL
-319	NULL
bp	NULL
and	NULL
-219	NULL
bp	NULL
.	NULL

However	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
additional	NULL
upstream	NULL
enhancer	NULL
elements	NULL
can	NULL
not	NULL
be	NULL
ruled	NULL
out	NULL
.	NULL

Sp1	NULL
and	NULL
AP	NULL
-2	NULL
transactivate	NULL
the	NULL
ASM	NULL
promoter	NULL
Within	NULL
the	NULL
DNA	NULL
sequence	NULL
upstream	NULL
of	NULL
the	NULL
ASM	NULL
gene	NULL
transcription	NULL
start	NULL
site	NULL
,	NULL
several	NULL
putative	NULL
cis-acting	NULL
consensus	NULL
sequences	NULL
are	NULL
present	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

These	NULL
include	NULL
binding	NULL
sites	NULL
for	NULL
transcription	NULL
factors	NULL
c-Myc	NULL
,	NULL
CREBP	NULL
,	NULL
AP-2	NULL
,	NULL
Sp1	NULL
,	NULL
and	NULL
PU.1	NULL
(	NULL
31-35	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
the	NULL
deletion	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL
ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
3B	NULL
)	NULL
,	NULL
construct	NULL
p	NULL
(	NULL
-219/	NULL
+112	NULL
)	NULL
Luc	NULL
,	NULL
which	NULL
contains	NULL
only	NULL
the	NULL
two	NULL
PU.1	NULL
binding	NULL
sites	NULL
,	NULL
shows	NULL
no	NULL
basal	NULL
or	NULL
PMAinduc-ible	NULL
promoter	NULL
activity	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
PU.1	NULL
alone	NULL
may	NULL
not	NULL
play	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
ASM	NULL
gene	NULL
expression	NULL
.	NULL

To	NULL
further	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
we	NULL
co-transfected	NULL
THP	NULL
-1	NULL
cells	NULL
with	NULL
the	NULL
longest	NULL
construct	NULL
p	NULL
(	NULL
-519/	NULL
+112	NULL
)	NULL
Luc	NULL
and	NULL
expression	NULL
vectors	NULL
for	NULL
Myc	NULL
(	NULL
pCMV	NULL
Myc	NULL
)	NULL
,	NULL
AP-2a	NULL
(	NULL
pCMVAP2a	NULL
)	NULL
,	NULL
Spl	NULL
(	NULL
pPacSp1	NULL
)	NULL
,	NULL
and	NULL
BTEB	NULL
(	NULL
pCMVBTEB	NULL
)	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
Spl	NULL
and	NULL
AP-2	NULL
caused	NULL
constitutive	NULL
augmentation	NULL
of	NULL
ASM	NULL
promoter	NULL
activity	NULL
(	NULL
1.8-fold	NULL
,	NULL
and	NULL
2.6	NULL
-fold	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
which	NULL
could	NULL
be	NULL
further	NULL
enhanced	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
Spl	NULL
and	NULL
AP-2	NULL
(	NULL
3.2-fold	NULL
)	NULL
.	NULL

c-Myc	NULL
lowered	NULL
luciferase	NULL
expression	NULL
(	NULL
0.7-fold	NULL
)	NULL
and	NULL
cotransfection	NULL
of	NULL
BTEB	NULL
,	NULL
an	NULL
Spl-4elated	NULL
transcription	NULL
factor	NULL
,	NULL
did	NULL
not	NULL
affect	NULL
ASM	NULL
promoter	NULL
activity	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
Spl	NULL
site	NULL
at	NULL
-279	NULL
and	NULL
the	NULL
AP-2	NULL
site	NULL
at	NULL
-289	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
ASM	NULL
promoter	NULL
activity	NULL
,	NULL
luciferase	NULL
constructs	NULL
with	NULL
mutated	NULL
binding	NULL
sites	NULL
were	NULL
transfected	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
Spl	NULL
site	NULL
,	NULL
the	NULL
AP-2	NULL
site	NULL
,	NULL
or	NULL
both	NULL
significantly	NULL
reduced	NULL
basal	NULL
and	NULL
inducible	NULL
promoter	NULL
activity	NULL
;	NULL
however	NULL
,	NULL
it	NULL
did	NULL
not	NULL
entirely	NULL
abolish	NULL
activity	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
Spl	NULL
and	NULL
AP2	NULL
A	NULL
220000	NULL
200000	NULL
180000	NULL
160000	NULL
|	NULL
140000	NULL
120000	NULL
100000	NULL
80000	NULL
60000	NULL
j	NULL
40000	NULL
-	NULL
I	NULL
20000	NULL
I	NULL
o	NULL
pCMV	NULL
Sp1	NULL
AP-2	NULL
Myc	NULL
-	NULL
BETEB	NULL
Sp1+	NULL
AP-2	NULL
relative	NULL
light	NULL
units	NULL
are	NULL
relevant	NULL
and	NULL
necessary	NULL
for	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
ASM	NULL
promoter	NULL
and	NULL
that	NULL
c-Myc	NULL
may	NULL
function	NULL
as	NULL
a	NULL
negative	NULL
regulator	NULL
.	NULL

Characterization	NULL
of	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
ASM	NULL
promoter	NULL
To	NULL
identify	NULL
nuclear	NULL
proteins	NULL
that	NULL
interact	NULL
with	NULL
the	NULL
ASM	NULL
promoter	NULL
region	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
were	NULL
performed	NULL
.	NULL

The	NULL
studies	NULL
focused	NULL
on	NULL
three	NULL
regions	NULL
,	NULL
SIF	NULL
3	NULL
,	NULL
SIF	NULL
4	NULL
,	NULL
and	NULL
SIF	NULL
6	NULL
,	NULL
including	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
transcription	NULL
factors	NULL
Spl	NULL
and	NULL
AP-2	NULL
,	NULL
which	NULL
were	NULL
shown	NULL
to	NULL
induce	NULL
ASM	NULL
promoter	NULL
activity	NULL
in	NULL
co-transfection	NULL
experiments	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

SIF	NULL
3	NULL
(	NULL
-310/	NULL
-270	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
overlapping	NULL
binding	NULL
sites	NULL
for	NULL
AP-2	NULL
and	NULL
Spl	NULL
interacts	NULL
with	NULL
proteins	NULL
in	NULL
both	NULL
control	NULL
and	NULL
induced	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
8	NULL
)	NULL
.	NULL

However	NULL
,	NULL
complexes	NULL
appeared	NULL
to	NULL
be	NULL
more	NULL
intense	NULL
when	NULL
PMA-induced	NULL
extracts	NULL
were	NULL
used	NULL
.	NULL

Binding	NULL
was	NULL
specific	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
effective	NULL
competition	NULL
of	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
9	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
AP-2	NULL
and	NULL
Spl	NULL
consensus	NULL
oligonucleotides	NULL
competed	NULL
for	NULL
the	NULL
binding	NULL
activity	NULL
in	NULL
both	NULL
extracts	NULL
,	NULL
whereas	NULL
NFKB	NULL
,	NULL
AP-1	NULL
,	NULL
B	NULL
WT	NULL
-299	NULL
CGTGCGCCCGGGGCAGGGCGGGGG	NULL
-276	NULL
mAP-2	NULL
-299	NULL
CGTGCGAACGGAACAGC	NULL
mSspl	NULL
-299	NULL
CGTGCGCCCGGGGCAG	NULL
mSpl/AP-2	NULL
-299	NULL
CGTGCGAACGGAACAGGGAAAGGG	NULL
-276	NULL
250000	NULL
-	NULL
e	NULL
__	NULL
|	NULL
.Cor=troiT	NULL
T	NULL
PMA	NULL
|	NULL
200000	NULL
|	NULL
&	NULL
5	NULL
150000	NULL
im	NULL
2	NULL
|	NULL
J	NULL
Ss	NULL
E	NULL
100000	NULL
a	NULL
|	NULL
50000	NULL
L.	NULL
[	NULL
0	NULL
[	NULL
_j	NULL
min	NULL
[	NULL
_	NULL
]	NULL
}	NULL
1	NULL
|	NULL
WT	NULL
mAP-2	NULL
mSp1	NULL
mSpt/AP-2	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Spl	NULL
and	NULL
AP-2	NULL
can	NULL
transactivate	NULL
the	NULL
ASM	NULL
promoter	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
co-transfected	NULL
with	NULL
10	NULL
jug	NULL
of	NULL
p	NULL
(	NULL
-519/	NULL
+112	NULL
)	NULL
Luc	NULL
promoter	NULL
construct	NULL
and	NULL
50	NULL
ng	NULL
of	NULL
transcription	NULL
factor	NULL
expression	NULL
plasmids	NULL
for	NULL
Spl	NULL
(	NULL
pPacSp1l	NULL
)	NULL
,	NULL
AP2	NULL
«	NULL
(	NULL
pCMVAP-2a	NULL
)	NULL
,	NULL
Myc	NULL
(	NULL
pCMVMyc	NULL
)	NULL
,	NULL
and	NULL
BTEB	NULL
(	NULL
pCMVBTEB	NULL
)	NULL
in	NULL
individual	NULL
experiments	NULL
or	NULL
in	NULL
combination	NULL
.	NULL

pCMV	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
for	NULL
the	NULL
amount	NULL
of	NULL
DNA	NULL
in	NULL
each	NULL
sample	NULL
and	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
ASM	NULL
promoter	NULL
activity	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Mutation	NULL
of	NULL
the	NULL
Sp1	NULL
and	NULL
AP-2	NULL
site	NULL
significantly	NULL
reduces	NULL
ASM	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
wild	NULL
type	NULL
construct	NULL
p	NULL
(	NULL
-319/	NULL
+112	NULL
)	NULL
(	NULL
WT	NULL
)	NULL
or	NULL
the	NULL
constructs	NULL
mAP-2	NULL
,	NULL
mSp1	NULL
,	NULL
and	NULL
mSp1/	NULL
AP-2	NULL
which	NULL
contain	NULL
base	NULL
pair	NULL
substitutions	NULL
in	NULL
the	NULL
binding	NULL
sites	NULL
for	NULL
AP-2	NULL
,	NULL
Sp1	NULL
,	NULL
or	NULL
for	NULL
both	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
were	NULL
transfected	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
PMA	NULL
for	NULL
48	NULL
h	NULL
and	NULL
the	NULL
luciferase	NULL
activity	NULL
was	NULL
determined	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
assayed	NULL
in	NULL
triplicate	NULL
for	NULL
luciferase	NULL
activity	NULL
and	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
four	NULL
experiments	NULL
.	NULL

Black	NULL
bars	NULL
show	NULL
basal	NULL
(	NULL
uninduced	NULL
)	NULL
activity	NULL
of	NULL
each	NULL
promoter	NULL
construct	NULL
and	NULL
grey	NULL
bars	NULL
indicate	NULL
PMA-induced	NULL
levels	NULL
of	NULL
activity	NULL
.	NULL

Consen-	NULL
sus	NULL
binding	NULL
sites	NULL
for	NULL
Sp1	NULL
and	NULL
AP-2	NULL
are	NULL
underlined	NULL
.	NULL

Langmann	NULL
e	NULL
al	NULL
.	NULL

-	NULL
Spl	NULL
and	NULL
AP-2	NULL
mediate	NULL
sphingomyelinase	NULL
induction	NULL
in	NULL
monocytes	NULL
875	NULL
6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL
ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
-	NULL
on	NULL
C	NULL
-a	NULL
l	NULL
irr	NULL
im	NULL
©	NULL
o	NULL
o	NULL
a.	NULL
p	NULL
|	NULL
§	NULL
s	NULL
3	NULL
s	NULL
3	NULL
l	NULL
8	NULL
3	NULL
3	NULL
s	NULL
s	NULL
<	NULL
M	NULL
Control	NULL
T	NULL
PMA	NULL
|	NULL
<	NULL
-	NULL
Sp1	NULL
+-	NULL
AP2	NULL
_|	NULL
Sp1	NULL
___	NULL
]	NULL
aP2	NULL
AP2	NULL
_	NULL
Spi	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Binding	NULL
of	NULL
Spl	NULL
and	NULL
AP-2	NULL
is	NULL
enhanced	NULL
in	NULL
differentiated	NULL
THP-1	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
from	NULL
untreated	NULL
THP-1	NULL
cells	NULL
(	NULL
lanes	NULL
2-7	NULL
)	NULL
,	NULL
THP-1	NULL
cells	NULL
treated	NULL
with	NULL
PMA	NULL
for	NULL
24	NULL
h	NULL
(	NULL
lanes	NULL
8-13	NULL
)	NULL
or	NULL
purified	NULL
transcription	NULL
factors	NULL
(	NULL
lanes	NULL
14	NULL
,	NULL
15	NULL
)	NULL
and	NULL
incubated	NULL
with	NULL
the	NULL
radiolabeled	NULL
,	NULL
double-stranded	NULL
oligomer	NULL
SIF	NULL
3	NULL
(	NULL
-310/	NULL
-270	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
adjacent	NULL
binding	NULL
sites	NULL
for	NULL
Spl	NULL
and	NULL
AP2	NULL
.	NULL

Lane	NULL
1	NULL
(	NULL
P	NULL
)	NULL
,	NULL
free	NULL
probe	NULL
without	NULL
nuclear	NULL
extract	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
extract	NULL
from	NULL
untreated	NULL
THP-1	NULL
cells	NULL
(	NULL
control	NULL
extract	NULL
)	NULL
;	NULL
lane	NULL
3	NULL
(	NULL
self	NULL
)	NULL
,	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
as	NULL
competitor	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
control	NULL
extract	NULL
plus	NULL
Spl	NULL
antibody	NULL
;	NULL
lane	NULL
5	NULL
control	NULL
extract	NULL
plus	NULL
AP-2	NULL
antibody	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
control	NULL
extract	NULL
plus	NULL
PU.1	NULL
antibody	NULL
,	NULL
lane	NULL
7	NULL
,	NULL
control	NULL
extract	NULL
plus	NULL
Ets	NULL
antibody	NULL
;	NULL
lane	NULL
8	NULL
,	NULL
PMA	NULL
extract	NULL
;	NULL
lane	NULL
9	NULL
(	NULL
self	NULL
)	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
as	NULL
competitor	NULL
;	NULL
lane	NULL
10	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
Sp	NULL
1	NULL
antibody	NULL
;	NULL
lane	NULL
11	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
AP-2	NULL
antibody	NULL
;	NULL
lane	NULL
12	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
PU.1	NULL
antibody	NULL
,	NULL
lane	NULL
13	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
Ets	NULL
antibody	NULL
;	NULL
lane	NULL
14	NULL
(	NULL
AP-2	NULL
)	NULL
,	NULL
purified	NULL
AP-2	NULL
protein	NULL
;	NULL
lane	NULL
15	NULL
(	NULL
Sp1	NULL
)	NULL
,	NULL
purified	NULL
Sp1	NULL
protein	NULL
.	NULL

Specific	NULL
antibodies	NULL
used	NULL
are	NULL
indicated	NULL
above	NULL
the	NULL
lanes	NULL
.	NULL

Brackets	NULL
indicate	NULL
mobility	NULL
of	NULL
specific	NULL
Sp1	NULL
and	NULL
AP2	NULL
complexes	NULL
.	NULL

Arrows	NULL
indicate	NULL
supershifted	NULL
complexes	NULL
.	NULL

Diagram	NULL
below	NULL
EMSA	NULL
indicates	NULL
the	NULL
relative	NULL
location	NULL
of	NULL
consensus	NULL
binding	NULL
sites	NULL
within	NULL
the	NULL
probe	NULL
.	NULL

or	NULL
Ets	NULL
consensus	NULL
oligonucleotides	NULL
did	NULL
not	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Antibody	NULL
supershift	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
SIF3	NULL
to	NULL
further	NULL
characterize	NULL
the	NULL
transcription	NULL
factors	NULL
specifically	NULL
interacting	NULL
with	NULL
this	NULL
region	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
proteins	NULL
interacting	NULL
with	NULL
SIF	NULL
3	NULL
were	NULL
recognized	NULL
by	NULL
antibodies	NULL
against	NULL
both	NULL
the	NULL
AP-2	NULL
and	NULL
Sp1	NULL
transcription	NULL
factors	NULL
{	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
)	NULL
but	NULL
not	NULL
by	NULL
antibodies	NULL
against	NULL
PU.1	NULL
or	NULL
876	NULL
Journal	NULL
of	NULL
Lipid	NULL
Research	NULL
Volume	NULL
40	NULL
,	NULL
1999	NULL
Ets	NULL
factors	NULL
(	NULL
lanes	NULL
12	NULL
and	NULL
13	NULL
)	NULL
.	NULL

Additional	NULL
evidence	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
Sp1	NULL
and	NULL
AP-2	NULL
comes	NULL
from	NULL
binding	NULL
studies	NULL
with	NULL
purified	NULL
transcription	NULL
factors	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
14	NULL
and	NULL
15	NULL
)	NULL
and	NULL
from	NULL
EMSAs	NULL
using	NULL
oligonucleotide	NULL
SIF	NULL
3	NULL
MI	NULL
which	NULL
contains	NULL
a	NULL
mutant	NULL
AP-2/	NULL
Sp1	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

No	NULL
specific	NULL
retardation	NULL
bands	NULL
are	NULL
produced	NULL
with	NULL
SIF	NULL
3	NULL
MI	NULL
and	NULL
THP-1	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
mutant	NULL
nucleotides	NULL
are	NULL
necessary	NULL
for	NULL
binding	NULL
of	NULL
Spl	NULL
and	NULL
AP-2	NULL
.	NULL

These	NULL
experiments	NULL
clearly	NULL
demonstrate	NULL
an	NULL
inducible	NULL
AP2	NULL
and	NULL
Spl	NULL
binding	NULL
activity	NULL
in	NULL
THP-1	NULL
cells	NULL
treated	NULL
with	NULL
PMA	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
additional	NULL
consensus	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
ASM	NULL
promoter	NULL
are	NULL
functional	NULL
,	NULL
EMSAs	NULL
with	NULL
SIF	NULL
4	NULL
(	NULL
-269/	NULL
-229	NULL
)	NULL
and	NULL
SIF	NULL
6	NULL
(	NULL
-199/	NULL
-149	NULL
)	NULL
were	NULL
performed	NULL
.	NULL

SIF	NULL
4	NULL
contains	NULL
two	NULL
adjacent	NULL
Spl	NULL
binding	NULL
sites	NULL
and	NULL
SIF	NULL
6	NULL
includes	NULL
two	NULL
neighbouring	NULL
PU.1	NULL
and	NULL
one	NULL
Spl	NULL
consensus	NULL
se-quence	NULL
.	NULL

Similar	NULL
to	NULL
SIF	NULL
3	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
induced	NULL
THP	NULL
cells	NULL
exhibited	NULL
strong	NULL
binding	NULL
activity	NULL
compared	NULL
to	NULL
uninduced	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
and	NULL
supershift	NULL
analysis	NULL
demonstrated	NULL
that	NULL
Spl	NULL
was	NULL
present	NULL
in	NULL
the	NULL
shifted	NULL
complexes	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
anti-Sp1	NULL
antibodies	NULL
complex	NULL
formation	NULL
is	NULL
reduced	NULL
and	NULL
a	NULL
slower	NULL
migrating	NULL
complex	NULL
is	NULL
formed	NULL
.	NULL

4	NULL
O	NULL
W	NULL
+	NULL
p	NULL
&	NULL
&	NULL
|	NULL
8	NULL
|	NULL
8	NULL
sra	NULL
-	NULL
|	NULL
sirsm	NULL
|-	NULL
sirs	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
Sp1/	NULL
AP-2	NULL
site	NULL
reduces	NULL
specific	NULL
binding	NULL
of	NULL
Spl	NULL
and	NULL
AP-2	NULL
.	NULL

Double-stranded	NULL
oligonucleotides	NULL
SIF	NULL
3	NULL
and	NULL
SIF	NULL
3	NULL
MI	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
mutant	NULL
AP2/	NULL
Sp1	NULL
binding	NULL
site	NULL
,	NULL
were	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
PMA-induced	NULL
THP-1	NULL
cells	NULL
or	NULL
purified	NULL
transcription	NULL
factor	NULL
Sp1	NULL
.	NULL

Lane	NULL
1	NULL
(	NULL
P	NULL
)	NULL
,	NULL
free	NULL
probe	NULL
without	NULL
nuclear	NULL
extract	NULL
;	NULL
lane	NULL
2	NULL
(	NULL
Sp1	NULL
)	NULL
,	NULL
SIF	NULL
3	NULL
with	NULL
purified	NULL
Sp1	NULL
;	NULL
lane	NULL
3	NULL
(	NULL
Sp1	NULL
self	NULL
)	NULL
,	NULL
SIF	NULL
3	NULL
with	NULL
purified	NULL
Sp1	NULL
plus	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
as	NULL
competitor	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
SIF	NULL
3	NULL
MI	NULL
with	NULL
PMA	NULL
extract	NULL
;	NULL
lane	NULL
5	NULL
(	NULL
self	NULL
)	NULL
,	NULL
SIF	NULL
3	NULL
MI	NULL
with	NULL
PMA	NULL
extract	NULL
plus	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
as	NULL
competitor	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
SIF	NULL
3	NULL
with	NULL
PMA	NULL
extract	NULL
;	NULL
lane	NULL
7	NULL
(	NULL
self	NULL
)	NULL
,	NULL
SIF	NULL
3	NULL
with	NULL
PMA	NULL
extract	NULL
plus	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
as	NULL
competitor	NULL
.	NULL

Arrow	NULL
to	NULL
the	NULL
right	NULL
indicates	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
specific	NULL
complex	NULL
.	NULL

6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL
ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
M9	NULL
If	NULL
&	NULL
4	NULL
Sp-1	NULL
tut	NULL
\	NULL
1	NULL
u	NULL
<	NULL
A	NULL
spr	NULL
~	NULL
a	NULL
4	NULL
tut	NULL
©4	NULL
be	NULL
wie	NULL
#	NULL
4	NULL
-	NULL
.	NULL

w	NULL
,	NULL
,	NULL
&	NULL
&	NULL
tel	NULL
O	NULL
&	NULL
o	NULL
f	NULL
Sp1	NULL
-	NULL
Sp1	NULL
SIF	NULL
4	NULL
<	NULL
-	NULL
Sp1	NULL
j	NULL
Sp1	NULL
199	NULL
PU.1	NULL
PU.1	NULL
Sp1	NULL
SIF	NULL
6	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Spl	NULL
but	NULL
not	NULL
PU.1	NULL
binds	NULL
to	NULL
the	NULL
putative	NULL
sites	NULL
in	NULL
SIF	NULL
4	NULL
and	NULL
SIF	NULL
6	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
from	NULL
untreated	NULL
THP-1	NULL
cells	NULL
(	NULL
control	NULL
)	NULL
or	NULL
THP-1	NULL
cells	NULL
treated	NULL
with	NULL
PMA	NULL
for	NULL
24	NULL
h	NULL
(	NULL
PMA	NULL
)	NULL
and	NULL
incubated	NULL
with	NULL
the	NULL
radiolabeled	NULL
,	NULL
double-stranded	NULL
oligomers	NULL
SIF	NULL
4	NULL
(	NULL
-269/	NULL
-229	NULL
)	NULL
and	NULL
SIF	NULL
6	NULL
(	NULL
-199/	NULL
-149	NULL
)	NULL
.	NULL

A	NULL
)	NULL
complexes	NULL
formed	NULL
with	NULL
SIF	NULL
4	NULL
.	NULL

Lane	NULL
1	NULL
(	NULL
P	NULL
)	NULL
,	NULL
free	NULL
probe	NULL
without	NULL
nuclear	NULL
extract	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
extract	NULL
from	NULL
untreated	NULL
THP-1	NULL
cells	NULL
(	NULL
control	NULL
extract	NULL
)	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
control	NULL
extract	NULL
plus	NULL
Sp1	NULL
antibody	NULL
;	NULL
lane	NULL
4	NULL
control	NULL
extract	NULL
plus	NULL
AP-2	NULL
antibody	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
control	NULL
extract	NULL
plus	NULL
PU.1	NULL
antibody	NULL
,	NULL
lane	NULL
6	NULL
,	NULL
PMA	NULL
extract	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
Sp1	NULL
antibody	NULL
;	NULL
lane	NULL
8	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
AP-2	NULL
antibody	NULL
,	NULL
lane	NULL
9	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
PU.1	NULL
antibody	NULL
;	NULL
lane	NULL
10	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
Ets	NULL
antibody	NULL
.	NULL

B	NULL
)	NULL
complexes	NULL
formed	NULL
with	NULL
SIF	NULL
6	NULL
.	NULL

Lane	NULL
1	NULL
(	NULL
P	NULL
)	NULL
,	NULL
free	NULL
probe	NULL
without	NULL
nuclear	NULL
extract	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
PMA	NULL
extract	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
Sp1	NULL
antibody	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
AP-2	NULL
antibody	NULL
,	NULL
lane	NULL
5	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
PU.1	NULL
antibody	NULL
;	NULL
lane	NULL
6	NULL
,	NULL
PMA	NULL
extract	NULL
plus	NULL
Ets	NULL
antibody	NULL
;	NULL
lane	NULL
7	NULL
(	NULL
Co	NULL
)	NULL
,	NULL
extract	NULL
from	NULL
untreated	NULL
THP-1	NULL
cells	NULL
(	NULL
control	NULL
extract	NULL
)	NULL
.	NULL

Specific	NULL
antibodies	NULL
used	NULL
are	NULL
indicated	NULL
above	NULL
the	NULL
lanes	NULL
.	NULL

Arrow	NULL
indicates	NULL
supershifted	NULL
complex	NULL
;	NULL
bracket	NULL
indicates	NULL
specific	NULL
complex	NULL
.	NULL

Diagram	NULL
below	NULL
EMSA	NULL
indicates	NULL
the	NULL
relative	NULL
location	NULL
of	NULL
consensus	NULL
binding	NULL
sites	NULL
within	NULL
the	NULL
probe	NULL
.	NULL

DNaseI	NULL
footprint	NULL
analysis	NULL
of	NULL
the	NULL
ASM	NULL
promoter	NULL
In	NULL
order	NULL
to	NULL
demonstrate	NULL
the	NULL
binding	NULL
of	NULL
Spl	NULL
to	NULL
the	NULL
promoter	NULL
region	NULL
spanning	NULL
from	NULL
nt	NULL
-368	NULL
to	NULL
nt	NULL
-252	NULL
,	NULL
inde-pendently	NULL
,	NULL
DNaseI	NULL
footprinting	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
.	NULL

The	NULL
promoter	NULL
fragment	NULL
was	NULL
labeled	NULL
at	NULL
one	NULL
end	NULL
and	NULL
either	NULL
incubated	NULL
with	NULL
purified	NULL
Spl	NULL
protein	NULL
obtained	NULL
from	NULL
a	NULL
commercial	NULL
source	NULL
or	NULL
HeLa	NULL
nuclear	NULL
extracts	NULL
.	NULL

As	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
a	NULL
convincing	NULL
DNaselI	NULL
protected	NULL
region	NULL
is	NULL
detectable	NULL
that	NULL
colocalizes	NULL
with	NULL
the	NULL
Spl	NULL
binding	NULL
site	NULL
(	NULL
GC-box	NULL
)	NULL
present	NULL
in	NULL
EMSA-fragment	NULL
SIF	NULL
3	NULL
.	NULL

This	NULL
site	NULL
conforms	NULL
well	NULL
to	NULL
the	NULL
weight	NULL
matrix	NULL
analysis	NULL
prediction	NULL
of	NULL
Bucher	NULL
(	NULL
36	NULL
)	NULL
for	NULL
GC-boxes	NULL
.	NULL

Expression	NULL
of	NULL
Sp1	NULL
protein	NULL
is	NULL
enhanced	NULL
in	NULL
PMA-stimulated	NULL
THP	NULL
cells	NULL
We	NULL
have	NULL
found	NULL
that	NULL
Spl	NULL
protein	NULL
binds	NULL
to	NULL
the	NULL
ASM	NULL
promoter	NULL
in	NULL
differentiated	NULL
THP	NULL
cells	NULL
to	NULL
a	NULL
much	NULL
higher	NULL
extent	NULL
than	NULL
in	NULL
undifferentiated	NULL
THP-1	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
na	NULL
ture	NULL
of	NULL
the	NULL
mechanisms	NULL
in	NULL
volved	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
levels	NULL
of	NULL
Sp1	NULL
,	NULL
c-Jun	NULL
,	NULL
and	NULL
PU.1	NULL
proteins	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
both	NULL
cell	NULL
types	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
,	NULL
the	NULL
early	NULL
response	NULL
gene	NULL
c-Jun	NULL
is	NULL
induced	NULL
in	NULL
PMAtreated	NULL
THP-1	NULL
cells	NULL
,	NULL
whereas	NULL
PU.1	NULL
levels	NULL
are	NULL
equal	NULL
in	NULL
both	NULL
extracts	NULL
.	NULL

This	NULL
is	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
inducibility	NULL
of	NULL
c-Jun	NULL
by	NULL
PMA	NULL
and	NULL
the	NULL
lack	NULL
of	NULL
change	NULL
of	NULL
PU.1	NULL
protein	NULL
amount	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
monocytes	NULL
to	NULL
macrophages	NULL
.	NULL

The	NULL
content	NULL
of	NULL
Spl	NULL
protein	NULL
in	NULL
PMAtreated	NULL
THP-1	NULL
cells	NULL
was	NULL
much	NULL
greater	NULL
than	NULL
in	NULL
uninduced	NULL
THP-1	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
Sp1	NULL
is	NULL
nearly	NULL
absent	NULL
.	NULL

This	NULL
new	NULL
finding	NULL
may	NULL
indicate	NULL
that	NULL
ASM	NULL
induction	NULL
in	NULL
THP-1	NULL
cells	NULL
is	NULL
partially	NULL
mediated	NULL
by	NULL
an	NULL
increased	NULL
synthesis	NULL
of	NULL
Spl	NULL
and	NULL
its	NULL
binding	NULL
to	NULL
the	NULL
promoter	NULL
in	NULL
a	NULL
differentiation	NULL
dependent	NULL
manner	NULL
.	NULL

DISCUSSION	NULL
This	NULL
study	NULL
demonstrates	NULL
that	NULL
acid	NULL
sphingomyelinase	NULL
mRNA	NULL
is	NULL
induced	NULL
in	NULL
both	NULL
the	NULL
human	NULL
monocytic	NULL
leukemia	NULL
Langmann	NULL
e	NULL
al	NULL
.	NULL

-	NULL
Spl	NULL
and	NULL
AP-2	NULL
mediate	NULL
sphingomyelinase	NULL
induction	NULL
in	NULL
monocytes	NULL
877	NULL
6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL
ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
fpu	NULL
Sp1	NULL
M	NULL
M	NULL
O0	NULL
12	NULL
3	NULL
-	NULL
Hela	NULL
-252	NULL
#	NULL
€	NULL
B	NULL
#	NULL
-	NULL
#	NULL
#	NULL
ll	NULL
LJ	NULL
i	NULL
#	NULL
$	NULL
6	NULL
.	NULL

#	NULL
%	NULL
%	NULL
%	NULL
H	NULL
’	NULL
°	NULL
‘	NULL
.	NULL

+	NULL
%	NULL
#	NULL
%	NULL
Al	NULL
Si	NULL
*	NULL
°	NULL
P	NULL
``	NULL
-368	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
identifies	NULL
the	NULL
binding	NULL
of	NULL
Spl	NULL
to	NULL
the	NULL
-279	NULL
site	NULL
.	NULL

A	NULL
DNA	NULL
probe	NULL
spanning	NULL
from	NULL
-368	NULL
to	NULL
-252	NULL
was	NULL
tested	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
purified	NULL
Sp1	NULL
or	NULL
proteins	NULL
from	NULL
a	NULL
HeLa	NULL
nuclear	NULL
extract	NULL
.	NULL

Different	NULL
Sp1	NULL
and	NULL
DNase	NULL
I	NULL
concentrations	NULL
were	NULL
used	NULL
as	NULL
in-dicated	NULL
.	NULL

The	NULL
Sp1	NULL
footprint	NULL
is	NULL
indicated	NULL
schematically	NULL
at	NULL
the	NULL
right	NULL
.	NULL

M	NULL
,	NULL
G	NULL
+	NULL
A	NULL
sequencing	NULL
ladder	NULL
.	NULL

cell	NULL
line	NULL
THP-1	NULL
,	NULL
when	NULL
the	NULL
cells	NULL
are	NULL
treated	NULL
with	NULL
PMA	NULL
,	NULL
and	NULL
in	NULL
differentiating	NULL
mononuclear	NULL
phagocytes	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Nuclear	NULL
run-on	NULL
analysis	NULL
of	NULL
ASM	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
reveals	NULL
that	NULL
this	NULL
up-regulation	NULL
occurs	NULL
mainly	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
.	NULL

Experiments	NULL
with	NULL
actinomycin	NULL
D	NULL
provided	NULL
evidence	NULL
that	NULL
ASM	NULL
mRNA	NULL
stability	NULL
is	NULL
not	NULL
modulated	NULL
during	NULL
the	NULL
monocytic	NULL
differentiation	NULL
process	NULL
.	NULL

ASM	NULL
is	NULL
expressed	NULL
ubiquitously	NULL
,	NULL
but	NULL
transcriptional	NULL
induction	NULL
is	NULL
observed	NULL
only	NULL
in	NULL
myelomonocytic	NULL
cell	NULL
lines	NULL
such	NULL
as	NULL
U937	NULL
,	NULL
and	NULL
THP-	NULL
,	NULL
which	NULL
have	NULL
the	NULL
ability	NULL
to	NULL
differentiate	NULL
into	NULL
macrophage-like	NULL
cells	NULL
upon	NULL
PMA	NULL
treatment	NULL
,	NULL
and	NULL
in	NULL
differentiating	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
878	NULL
Journal	NULL
of	NULL
Lipid	NULL
Research	NULL
Volume	NULL
40	NULL
,	NULL
1999	NULL
Taipa	NULL
(	NULL
BP	NULL
+PMA	NULL
39	NULL
kDa	NULL
exammem	NULL
|	NULL
C-JUIN	NULL
45	NULL
kDa|	NULL
@	NULL
tamp	NULL
>	NULL
-mmm®	NULL
|	NULL
P|	NULL
]	NULL
{	NULL
95	NULL
kDa	NULL
|	NULL
°	NULL
Sp1	NULL
Fig	NULL
.	NULL

9	NULL
.	NULL

Expression	NULL
of	NULL
Spl	NULL
protein	NULL
is	NULL
induced	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
differentiated	NULL
THP-1	NULL
cells	NULL
.	NULL

20	NULL
pg	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
THP-1	NULL
cells	NULL
or	NULL
THP-1	NULL
cells	NULL
treated	NULL
with	NULL
PMA	NULL
for	NULL
24	NULL
hours	NULL
were	NULL
laid	NULL
on	NULL
the	NULL
gel	NULL
.	NULL

After	NULL
blotting	NULL
,	NULL
c-Jun	NULL
,	NULL
PU.1	NULL
or	NULL
Sp1	NULL
protein	NULL
was	NULL
detected	NULL
by	NULL
incubation	NULL
with	NULL
a	NULL
specific	NULL
polyclonal	NULL
antibody	NULL
.	NULL

A	NULL
representative	NULL
autoradiogram	NULL
is	NULL
shown	NULL
.	NULL

increased	NULL
ASM	NULL
activity	NULL
may	NULL
reflect	NULL
a	NULL
characteristic	NULL
function	NULL
of	NULL
mature	NULL
macrophages	NULL
,	NULL
namely	NULL
,	NULL
phagocytosis	NULL
of	NULL
senescent	NULL
cells	NULL
and	NULL
other	NULL
particles	NULL
and	NULL
subsequent	NULL
degradation	NULL
of	NULL
sphingomyelin	NULL
derived	NULL
from	NULL
the	NULL
internalized	NULL
material	NULL
.	NULL

This	NULL
provided	NULL
the	NULL
rationale	NULL
for	NULL
investigation	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
ASM	NULL
expression	NULL
by	NULL
analyzing	NULL
as-regulatory	NULL
elements	NULL
in	NULL
the	NULL
ASM	NULL
promoter	NULL
and	NULL
the	NULL
corresponding	NULL
transcription	NULL
fac-tors	NULL
.	NULL

We	NULL
studied	NULL
the	NULL
activity	NULL
of	NULL
five	NULL
ASM	NULL
promoter	NULL
constructs	NULL
by	NULL
ligating	NULL
them	NULL
in	NULL
front	NULL
of	NULL
the	NULL
firefly	NULL
luciferase	NULL
reporter	NULL
gene	NULL
and	NULL
used	NULL
a	NULL
transient	NULL
transfection	NULL
system	NULL
in	NULL
the	NULL
THP	NULL
-1	NULL
cell	NULL
line	NULL
.	NULL

Promoter	NULL
fragments	NULL
p	NULL
(	NULL
-519/	NULL
+112	NULL
)	NULL
Luc	NULL
,	NULL
p	NULL
(	NULL
-419/	NULL
+112	NULL
)	NULL
Luc	NULL
,	NULL
and	NULL
p	NULL
(	NULL
-319/	NULL
+112	NULL
)	NULL
Luc	NULL
exhibited	NULL
basal	NULL
and	NULL
PMA-induced	NULL
luciferase	NULL
activity	NULL
;	NULL
however	NULL
,	NULL
all	NULL
activity	NULL
,	NULL
including	NULL
PMA-induced	NULL
activity	NULL
was	NULL
lost	NULL
using	NULL
the	NULL
shorter	NULL
promoter	NULL
fragments	NULL
p	NULL
(	NULL
-219/	NULL
+112	NULL
)	NULL
Luec	NULL
and	NULL
p	NULL
(	NULL
-119/	NULL
+112	NULL
)	NULL
Luc	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
promoter	NULL
region	NULL
that	NULL
confers	NULL
PMA-mediated	NULL
transactivation	NULL
of	NULL
the	NULL
ASM	NULL
gene	NULL
was	NULL
identified	NULL
.	NULL

This	NULL
GC-rich	NULL
DNA	NULL
sequence	NULL
contains	NULL
multiple	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
,	NULL
including	NULL
two	NULL
adjacent	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
transcription	NULL
factors	NULL
Spl	NULL
and	NULL
AP-2	NULL
.	NULL

These	NULL
two	NULL
factors	NULL
are	NULL
necessary	NULL
for	NULL
the	NULL
basal	NULL
and	NULL
PMA-induced	NULL
activation	NULL
of	NULL
the	NULL
ASM	NULL
promoter	NULL
as	NULL
demonstrated	NULL
by	NULL
transactivation	NULL
studies	NULL
and	NULL
site-directed	NULL
mutagenesis	NULL
.	NULL

This	NULL
region	NULL
was	NULL
subsequently	NULL
analyzed	NULL
in	NULL
EMSAs	NULL
and	NULL
DNaselI	NULL
footprinting	NULL
experiments	NULL
.	NULL

These	NULL
analyses	NULL
revealed	NULL
a	NULL
specific	NULL
complex	NULL
formation	NULL
with	NULL
Spl	NULL
and	NULL
AP-2	NULL
that	NULL
is	NULL
largely	NULL
enhanced	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
differentiated	NULL
THP-1	NULL
cells	NULL
.	NULL

The	NULL
ASM	NULL
proximal	NULL
promoter	NULL
is	NULL
GC-rich	NULL
and	NULL
lacks	NULL
a	NULL
TATA	NULL
sequence	NULL
motif	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
TATA	NULL
box	NULL
,	NULL
mechanisms	NULL
other	NULL
than	NULL
direct	NULL
recruitment	NULL
of	NULL
TBPs	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
initiating	NULL
the	NULL
basal	NULL
transcription	NULL
complex	NULL
.	NULL

Sp	NULL
1	NULL
transcription	NULL
factors	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
constituents	NULL
for	NULL
correct	NULL
transcription	NULL
initiation	NULL
from	NULL
TATAess	NULL
promoters	NULL
(	NULL
37-39	NULL
)	NULL
.	NULL

Although	NULL
Sp1	NULL
is	NULL
ubiquitously	NULL
expressed	NULL
,	NULL
recent	NULL
evidence	NULL
suggests	NULL
that	NULL
Spl	NULL
expression	NULL
(	NULL
40	NULL
)	NULL
,	NULL
binding	NULL
affinity	NULL
(	NULL
41	NULL
)	NULL
,	NULL
and	NULL
post-transcriptional	NULL
modifications	NULL
(	NULL
42	NULL
,	NULL
43	NULL
)	NULL
may	NULL
be	NULL
modulated	NULL
to	NULL
confer	NULL
tissue-specific	NULL
and	NULL
developmental	NULL
regulation	NULL
on	NULL
target	NULL
genes	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Spl	NULL
expression	NULL
varies	NULL
greatly	NULL
among	NULL
tissues	NULL
,	NULL
6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL
ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
with	NULL
hematopoetic	NULL
cells	NULL
containing	NULL
very	NULL
high	NULL
levels	NULL
of	NULL
Spl	NULL
mRNA	NULL
and	NULL
protein	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Spl	NULL
is	NULL
involved	NULL
in	NULL
transcription	NULL
of	NULL
many	NULL
cell-type	NULL
specific	NULL
genes	NULL
,	NULL
including	NULL
the	NULL
myeloid	NULL
specific	NULL
integrin	NULL
CD11b	NULL
(	NULL
45	NULL
)	NULL
,	NULL
the	NULL
monocytic	NULL
specific	NULL
gene	NULL
CD14	NULL
(	NULL
46	NULL
)	NULL
,	NULL
the	NULL
liver	NULL
specific	NULL
«	NULL
1	NULL
acid	NULL
glycoprotein	NULL
(	NULL
47	NULL
)	NULL
,	NULL
and	NULL
the	NULL
«	NULL
2	NULL
integrin	NULL
gene	NULL
(	NULL
48	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
appear	NULL
to	NULL
be	NULL
valid	NULL
for	NULL
the	NULL
ASM	NULL
promoter	NULL
as	NULL
well	NULL
,	NULL
as	NULL
our	NULL
studies	NULL
showed	NULL
an	NULL
increased	NULL
binding	NULL
affinity	NULL
for	NULL
Spl	NULL
in	NULL
EMSAs	NULL
and	NULL
enhanced	NULL
promoter	NULL
activity	NULL
in	NULL
cotransfection	NULL
experiments	NULL
using	NULL
a	NULL
Spl	NULL
expression	NULL
vector	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
elimination	NULL
of	NULL
the	NULL
Spl	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
ASM	NULL
promoter	NULL
resulted	NULL
in	NULL
an	NULL
almost	NULL
complete	NULL
elimination	NULL
of	NULL
both	NULL
basal	NULL
and	NULL
PMA-induced	NULL
promoter	NULL
activity	NULL
.	NULL

Recent	NULL
studies	NULL
showed	NULL
that	NULL
Spl	NULL
is	NULL
implicated	NULL
in	NULL
the	NULL
PMA-induced	NULL
expression	NULL
of	NULL
the	NULL
WAF/	NULL
CIP1	NULL
gene	NULL
in	NULL
U937	NULL
cells	NULL
and	NULL
the	NULL
thromboxane	NULL
receptor	NULL
gene	NULL
expression	NULL
in	NULL
K562	NULL
cells	NULL
(	NULL
49	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
Sp	NULL
1	NULL
protein	NULL
levels	NULL
increase	NULL
during	NULL
PMA-mediated	NULL
differentiation	NULL
of	NULL
THP-1	NULL
cells	NULL
,	NULL
immunoblots	NULL
with	NULL
THP-nuclear	NULL
extracts	NULL
were	NULL
carried	NULL
out	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
Spl	NULL
protein	NULL
is	NULL
markedly	NULL
increased	NULL
in	NULL
PMA-induced	NULL
THP-1	NULL
cells	NULL
.	NULL

The	NULL
transfection	NULL
experiments	NULL
and	NULL
EMSAs	NULL
also	NULL
demonstrated	NULL
that	NULL
the	NULL
transcription	NULL
factor	NULL
AP2	NULL
is	NULL
critically	NULL
involved	NULL
in	NULL
the	NULL
regulated	NULL
expression	NULL
of	NULL
the	NULL
ASM	NULL
gene	NULL
during	NULL
monocyte	NULL
to	NULL
macrophage	NULL
differentiation	NULL
.	NULL

AP2	NULL
is	NULL
an	NULL
inducible	NULL
nuclear	NULL
factor	NULL
controlling	NULL
gene	NULL
expression	NULL
in	NULL
embryonic	NULL
development	NULL
and	NULL
cellular	NULL
differentiation	NULL
(	NULL
50	NULL
)	NULL
.	NULL

AP-2	NULL
transactivation	NULL
is	NULL
subject	NULL
to	NULL
multiple	NULL
regulatory	NULL
mech-anisms	NULL
.	NULL

Phorbol	NULL
esters	NULL
and	NULL
cAMP-regulated	NULL
signalling	NULL
have	NULL
been	NULL
found	NULL
to	NULL
induce	NULL
AP-2	NULL
activity	NULL
independent	NULL
of	NULL
increased	NULL
mRNA	NULL
and	NULL
protein	NULL
levels	NULL
(	NULL
51	NULL
)	NULL
.	NULL

However	NULL
,	NULL
terato-carcinoma	NULL
cells	NULL
stimulated	NULL
with	NULL
retinoic	NULL
acid	NULL
show	NULL
increased	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
AP-2	NULL
gene	NULL
(	NULL
52	NULL
)	NULL
.	NULL

AP-2	NULL
activity	NULL
can	NULL
also	NULL
be	NULL
down-regulated	NULL
by	NULL
an	NULL
alternative	NULL
splice	NULL
product	NULL
of	NULL
its	NULL
own	NULL
gene	NULL
(	NULL
53	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
the	NULL
ASM	NULL
promoter	NULL
revealed	NULL
two	NULL
binding	NULL
sites	NULL
for	NULL
PU.1	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
which	NULL
is	NULL
restricted	NULL
to	NULL
macrophages	NULL
and	NULL
B-cells	NULL
(	NULL
35	NULL
)	NULL
.	NULL

PU.1	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
cell-specific	NULL
expression	NULL
of	NULL
several	NULL
genes	NULL
,	NULL
including	NULL
the	NULL
macrophage	NULL
scavenger	NULL
receptor	NULL
gene	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Using	NULL
EMSAs	NULL
we	NULL
provide	NULL
evidence	NULL
that	NULL
PU.1	NULL
does	NULL
not	NULL
play	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
ASM	NULL
gene	NULL
expression	NULL
in	NULL
differentiating	NULL
THP-1	NULL
cells	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
the	NULL
transcription	NULL
factors	NULL
Spl	NULL
and	NULL
AP-2	NULL
are	NULL
required	NULL
for	NULL
the	NULL
up	NULL
regulation	NULL
of	NULL
ASM	NULL
expression	NULL
during	NULL
monocytic	NULL
differentiation	NULL
.	NULL

In	NULL
the	NULL
fu-ture	NULL
,	NULL
it	NULL
will	NULL
be	NULL
of	NULL
great	NULL
interest	NULL
to	NULL
study	NULL
whether	NULL
these	NULL
two	NULL
transcriptional	NULL
activators	NULL
might	NULL
also	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
other	NULL
genes	NULL
during	NULL
monocytic	NULL
differentiation	NULL
.	NULL

MB	NULL
We	NULL
acknowledge	NULL
the	NULL
generous	NULL
gift	NULL
of	NULL
expression	NULL
vectors	NULL
,	NULL
pPacSp1	NULL
from	NULL
Dr.	NULL
R.	NULL
Tjian	NULL
,	NULL
and	NULL
pCMVAP2	NULL
,	NULL
pCMVMyc	NULL
,	NULL
and	NULL
pCMVBTEB	NULL
from	NULL
Dr.	NULL
R.	NULL
Buettner	NULL
.	NULL

We	NULL
thank	NULL
R.	NULL
Glitzl	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
within	NULL
the	NULL
For-schergruppe	NULL
``	NULL
Molekulare	NULL
Grundlagen	NULL
der	NULL
Differenzierung	NULL
und	NULL
Aktivierung	NULL
mononuklei	NULL
#	NULL
rer	NULL
Phagozyten	NULL
``	NULL
(	NULL
AN	NULL
111/	NULL
6-1	NULL
)	NULL
.	NULL

Manuscript	NULL
received	NULL
11	NULL
November	NULL
1998	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
27	NULL
January	NULL
1999	NULL
.	NULL

Langmann	NULL
e	NULL
al	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

REFERENCES	NULL
.	NULL

Levade	NULL
,	NULL
T.	NULL
,	NULL
R.	NULL
Salvayre	NULL
,	NULL
and	NULL
L.	NULL
Douste-Blazy	NULL
.	NULL

1986	NULL
.	NULL

Sphingomyeli-	NULL
nases	NULL
and	NULL
Niemann-Pick	NULL
disease	NULL
.	NULL

J	NULL
Clin	NULL
.	NULL

Chem	NULL
.	NULL

Clin	NULL
.	NULL

Biochen	NULL
.	NULL

24	NULL
:	NULL
205-220.	NULL
.	NULL

Quintern	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
G.	NULL
Weitz	NULL
,	NULL
H.	NULL
Nehrkortn	NULL
,	NULL
J.	NULL
M.	NULL
Tager	NULL
,	NULL
A.	NULL
W.	NULL
Schram	NULL
,	NULL
and	NULL
K.	NULL
Sandhoff	NULL
.	NULL

1987	NULL
.	NULL

Acid	NULL
sphingomyelinase	NULL
from	NULL
human	NULL
urine	NULL
:	NULL
purification	NULL
and	NULL
characterization	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
.	NULL

9221	NULL
323-336.	NULL
.	NULL

Brady	NULL
,	NULL
R.	NULL
O.	NULL
,	NULL
J.	NULL
N.	NULL
Kanfer	NULL
,	NULL
M.	NULL
B.	NULL
Mock	NULL
,	NULL
and	NULL
D.	NULL
S.	NULL
Frederickson	NULL
.	NULL

1966	NULL
.	NULL

The	NULL
metabolism	NULL
of	NULL
sphingomyelin	NULL
.	NULL

II	NULL
.	NULL

Evidence	NULL
of	NULL
an	NULL
enzy-matic	NULL
deficiency	NULL
in	NULL
Niemann-Pick	NULL
disease	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

551	NULL
366-370.	NULL
.	NULL

Schneider	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
and	NULL
E.	NULL
P.	NULL
Kennedy	NULL
.	NULL

1967	NULL
.	NULL

Sphingomyelinase	NULL
in	NULL
normal	NULL
human	NULL
spleens	NULL
and	NULL
in	NULL
spleens	NULL
from	NULL
subjects	NULL
with	NULL
Niemann-Pick	NULL
disease	NULL
.	NULL

J	NULL
Lipid	NULL
Res	NULL
.	NULL

8	NULL
:	NULL
202-208.	NULL
.	NULL

Otterbach	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
W.	NULL
Stoffel	NULL
.	NULL

1995	NULL
.	NULL

Acid	NULL
sphingomyelinase	NULL
deficient	NULL
mice	NULL
mimic	NULL
the	NULL
neurovisceral	NULL
form	NULL
of	NULL
human	NULL
lysosomal	NULL
storage	NULL
disease	NULL
(	NULL
Niemann-Pick	NULL
disease	NULL
)	NULL
.	NULL

Cell	NULL
.	NULL

81	NULL
:	NULL
1053-1061.	NULL
.	NULL

Horinouchi	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Erlich	NULL
,	NULL
D.	NULL
P.	NULL
Perl	NULL
,	NULL
K.	NULL
Ferlinz	NULL
,	NULL
C.	NULL
L.	NULL
Bisgaier	NULL
,	NULL
K.	NULL
Sandhoff	NULL
,	NULL
R.	NULL
J.	NULL
Desnick	NULL
,	NULL
C.	NULL
L.	NULL
Stewart	NULL
,	NULL
and	NULL
E.	NULL
H.	NULL
Schuchman	NULL
.	NULL

1995	NULL
.	NULL

Acid	NULL
sphingomyelinase-deficient	NULL
mice	NULL
:	NULL
a	NULL
model	NULL
of	NULL
types	NULL
A	NULL
and	NULL
B	NULL
Niemann-Pick	NULL
disease	NULL
.	NULL

Nat	NULL
.	NULL

Genet	NULL
.	NULL

10	NULL
:	NULL
288-293.	NULL
.	NULL

Schiitze	NULL
,	NULL
S.	NULL
,	NULL
K.	NULL
Potthoff	NULL
,	NULL
T.	NULL
Machleidt	NULL
,	NULL
D.	NULL
Berkovic	NULL
,	NULL
K.	NULL
Wiegmann	NULL
,	NULL
and	NULL
M.	NULL
Kronke	NULL
.	NULL

1992	NULL
.	NULL

TNF	NULL
activates	NULL
NF-kappa	NULL
B	NULL
by	NULL
phosphatidyl-choline-specific	NULL
phospholipase	NULL
Cinduced	NULL
``	NULL
acidic	NULL
``	NULL
sphingomyelin	NULL
breakdown	NULL
.	NULL

Cell	NULL
.	NULL

71	NULL
:	NULL
765-776.	NULL
.	NULL

Wiegmann	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Schiitze	NULL
,	NULL
T.	NULL
Machleidt	NULL
,	NULL
D.	NULL
Witte	NULL
,	NULL
and	NULL
M.	NULL
Kronke	NULL
.	NULL

1994	NULL
.	NULL

Functional	NULL
dichotomy	NULL
of	NULL
neutral	NULL
and	NULL
acidic	NULL
sphingomyeli-nases	NULL
in	NULL
tumor	NULL
necrosis	NULL
factor	NULL
signaling	NULL
.	NULL

Cell	NULL
.	NULL

78	NULL
:	NULL
1005-1015.	NULL
.	NULL

Kuno	NULL
,	NULL
K.	NULL
,	NULL
K.	NULL
Sukegawa	NULL
,	NULL
Y	NULL
Ishikawa	NULL
,	NULL
T.	NULL
Orii	NULL
,	NULL
and	NULL
K.	NULL
Matsushima	NULL
.	NULL

1994	NULL
.	NULL

Acid	NULL
sphingomyelinase	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
the	NULL
IL-1	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
signaling	NULL
pathway	NULL
leading	NULL
to	NULL
NFkB	NULL
activation	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

6	NULL
:	NULL
1269-1272	NULL
.	NULL

Zumbansen	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
W.	NULL
Stoffel	NULL
.	NULL

1997	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
activates	NULL
NFkappaB	NULL
in	NULL
acid	NULL
sphingomyelinase-deficient	NULL
mouse	NULL
embryonic	NULL
fibroblasts	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chen	NULL
.	NULL

16	NULL
:	NULL
10904-10909	NULL
.	NULL

Schuchman	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
M.	NULL
Suchi	NULL
,	NULL
T.	NULL
Takahashi	NULL
,	NULL
K.	NULL
Sandhoff	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Desnick	NULL
.	NULL

1991	NULL
.	NULL

Human	NULL
acid	NULL
sphingomyelinase	NULL
.	NULL

Isolation	NULL
,	NULL
nucleotide	NULL
sequence	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
fulllength	NULL
and	NULL
alternatively	NULL
spliced	NULL
cDNAs	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chen	NULL
.	NULL

66	NULL
:	NULL
8531-8539	NULL
.	NULL

Schuchman	NULL
,	NULL
E.	NULL
H.	NULL
,	NULL
O.	NULL
Levran	NULL
,	NULL
L.	NULL
V.	NULL
Pereira	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Desnick	NULL
.	NULL

1992	NULL
.	NULL

Structural	NULL
organization	NULL
and	NULL
complete	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
human	NULL
acid	NULL
sphingomyelinase	NULL
(	NULL
SMPD1	NULL
)	NULL
.	NULL

Genomics	NULL
.	NULL

121	NULL
197-205	NULL
.	NULL

Pereira	NULL
,	NULL
L.	NULL
,	NULL
R.	NULL
J.	NULL
Desnick	NULL
,	NULL
D.	NULL
Adler	NULL
,	NULL
C.	NULL
B.	NULL
Disteche	NULL
,	NULL
and	NULL
E.	NULL
H.	NULL
Schuchman	NULL
.	NULL

1991	NULL
.	NULL

Regional	NULL
assignment	NULL
of	NULL
the	NULL
human	NULL
acid	NULL
sphingomyelinase	NULL
gene	NULL
(	NULL
SMPD1	NULL
)	NULL
by	NULL
PCR	NULL
analysis	NULL
of	NULL
somatic	NULL
cell	NULL
hybrids	NULL
and	NULL
in	NULL
situ	NULL
hybridization	NULL
to	NULL
11p15.1-p15.4	NULL
.	NULL

Genomics	NULL
.	NULL

9	NULL
:	NULL
8531-8539	NULL
.	NULL

Newrzella	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
W.	NULL
Stoffel	NULL
.	NULL

1992	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
the	NULL
acid	NULL
sphingomyelinase	NULL
of	NULL
the	NULL
mouse	NULL
and	NULL
the	NULL
organization	NULL
and	NULL
complete	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

Biol	NULL
Chen	NULL
.	NULL

Hoppe	NULL
Seyler	NULL
373	NULL
:	NULL
1233-1238	NULL
.	NULL

Schissel	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
E.	NULL
H.	NULL
Schuchman	NULL
,	NULL
K.	NULL
J.	NULL
Williams	NULL
,	NULL
and	NULL
I.	NULL
Tabas	NULL
.	NULL

1996	NULL
.	NULL

Zn2+-stimulated	NULL
sphingomyelinase	NULL
is	NULL
secreted	NULL
by	NULL
many	NULL
cell	NULL
types	NULL
and	NULL
is	NULL
a	NULL
product	NULL
of	NULL
the	NULL
acid	NULL
sphingomyelinase	NULL
gene	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chen	NULL
.	NULL

267	NULL
:	NULL
18431-18436	NULL
.	NULL

Schissel	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
X.	NULL
Jiang	NULL
,	NULL
J.	NULL
Tweedie-Hardman	NULL
,	NULL
T.	NULL
Jeong	NULL
,	NULL
E.	NULL
H.	NULL
Ca-mejo	NULL
,	NULL
J.	NULL
Najib	NULL
,	NULL
J.	NULL
H.	NULL
Rapp	NULL
,	NULL
K.	NULL
J.	NULL
Williams	NULL
,	NULL
and	NULL
I.	NULL
Tabas	NULL
.	NULL

1998	NULL
.	NULL

Secretory	NULL
sphingomyelinase	NULL
,	NULL
a	NULL
product	NULL
of	NULL
the	NULL
acid	NULL
sphingomyelinase	NULL
gene	NULL
,	NULL
can	NULL
hydrolyze	NULL
atherogenic	NULL
lipoproteins	NULL
at	NULL
neutral	NULL
pH	NULL
.	NULL

Implications	NULL
for	NULL
atherosclerotic	NULL
lesion	NULL
development	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chen	NULL
.	NULL

273	NULL
:	NULL
2738-2746	NULL
.	NULL

Marathe	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
L.	NULL
Schissel	NULL
,	NULL
M.	NULL
J.	NULL
Yellin	NULL
,	NULL
N.	NULL
Beatini	NULL
,	NULL
R.	NULL
Mintzer	NULL
,	NULL
K.	NULL
J.	NULL
Williams	NULL
,	NULL
and	NULL
I.	NULL
Tabas	NULL
.	NULL

1998	NULL
.	NULL

Human	NULL
vascular	NULL
endothelial	NULL
cells	NULL
are	NULL
a	NULL
rich	NULL
and	NULL
regulatable	NULL
source	NULL
of	NULL
secretory	NULL
sphingomyelinase	NULL
.	NULL

Implications	NULL
for	NULL
early	NULL
atherogenesis	NULL
and	NULL
ceramide-mediated	NULL
cell	NULL
signaling	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273	NULL
:	NULL
4081-4088	NULL
.	NULL

Gabig	NULL
,	NULL
T.	NULL
G.	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
Bahor	NULL
.	NULL

1981	NULL
.	NULL

The	NULL
killing	NULL
of	NULL
pathogenes	NULL
by	NULL
phagocytes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Med	NULL
.	NULL

32	NULL
:	NULL
313-326	NULL
.	NULL

Bauer	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
K.	NULL
Hannig	NULL
.	NULL

1988	NULL
.	NULL

Countercurrent	NULL
centrifugal	NULL
elutra-tion	NULL
in	NULL
a	NULL
table-top	NULL
centrifuge	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

Methods	NULL
.	NULL

112	NULL
:	NULL
213-218	NULL
.	NULL

Tsuchiya	NULL
,	NULL
S.	NULL
,	NULL
Y	NULL
Kobayashi	NULL
,	NULL
Y	NULL
Goto	NULL
,	NULL
H.	NULL
Okimura	NULL
,	NULL
S.	NULL
Nakae	NULL
,	NULL
T.	NULL
Konno	NULL
,	NULL
and	NULL
K.	NULL
Tada	NULL
.	NULL

1982	NULL
.	NULL

Induction	NULL
of	NULL
maturation	NULL
in	NULL
cultured	NULL
human	NULL
monocytic	NULL
leukemia	NULL
cells	NULL
by	NULL
a	NULL
phorbol	NULL
diester	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

42	NULL
:	NULL
1531-1536	NULL
.	NULL

Ioannou	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
C.	NULL
T.	NULL
Amemiya	NULL
,	NULL
J.	NULL
Garnes	NULL
,	NULL
P.	NULL
M.	NULL
Kroisel	NULL
,	NULL
S.	NULL
Hiroaki	NULL
,	NULL
Sp1	NULL
and	NULL
AP-2	NULL
mediate	NULL
sphingomyelinase	NULL
induction	NULL
in	NULL
monocytes	NULL
879	NULL
6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL
ASBMB	NULL
JOURNAL	NULL
OF	NULL
LIPID	NULL
RESEARCH	NULL
22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

880	NULL
C.	NULL
Chen	NULL
,	NULL
M.	NULL
A.	NULL
Batzer	NULL
,	NULL
and	NULL
P.	NULL
J	NULL
.	NULL

De	NULL
Jong	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
new	NULL
bacteriophage	NULL
P1-derived	NULL
vector	NULL
for	NULL
the	NULL
propagation	NULL
of	NULL
large	NULL
human	NULL
DNA	NULL
fragments	NULL
.	NULL

Nat	NULL
.	NULL

Genet	NULL
.	NULL

61	NULL
84-89	NULL
.	NULL

Innis	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

1990	NULL
.	NULL

PCR	NULL
with	NULL
7-deaza2'-deoxyguanosine	NULL
triphos-phate	NULL
.	NULL

In	NULL
PCR	NULL
Protocols	NULL
.	NULL

M.	NULL
A.	NULL
Innis	NULL
,	NULL
D.	NULL
H.	NULL
Gelfand	NULL
,	NULL
J.	NULL
J.	NULL
Sninsky	NULL
,	NULL
and	NULL
T.	NULL
J	NULL
.	NULL

White	NULL
,	NULL
editors	NULL
.	NULL

Academic	NULL
Press	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
.	NULL

54-59	NULL
.	NULL

Zaret	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
J.	NULL
K.	NULL
Liu	NULL
,	NULL
and	NULL
C.	NULL
M.	NULL
Di	NULL
Persio	NULL
.	NULL

1990	NULL
.	NULL

Site-directed	NULL
mu-tagenesis	NULL
reveals	NULL
a	NULL
liver	NULL
transcription	NULL
factor	NULL
essential	NULL
for	NULL
the	NULL
albumin	NULL
transcriptional	NULL
enhancer	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

87	NULL
:	NULL
5469-5473	NULL
.	NULL

Sompayrac	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
K.	NULL
J.	NULL
Danna	NULL
.	NULL

1981	NULL
.	NULL

Efficient	NULL
infection	NULL
of	NULL
monkey	NULL
cells	NULL
with	NULL
DNA	NULL
of	NULL
simian	NULL
virus	NULL
40	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

781	NULL
7575-1578	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
Clon-ing	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

2nd	NULL
Ed	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Labora-tory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
1311-1312	NULL
.	NULL

Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
A.	NULL
E.	NULL
Przybyla	NULL
,	NULL
R.	NULL
J.	NULL
MacDonald	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Rutter	NULL
.	NULL

1979	NULL
.	NULL

Isolation	NULL
of	NULL
biologically	NULL
active	NULL
ribonucleic	NULL
acid	NULL
from	NULL
sources	NULL
enriched	NULL
in	NULL
ribonuclease	NULL
.	NULL

Biochemistry	NULL
.	NULL

18	NULL
:	NULL
5294-5299	NULL
.	NULL

Srivastava	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
E.	NULL
E.	NULL
Cable	NULL
,	NULL
and	NULL
H.	NULL
L.	NULL
Bonkovsky	NULL
.	NULL

1993	NULL
.	NULL

Purifying	NULL
nascent	NULL
mRNA	NULL
from	NULL
nuclear	NULL
run-on	NULL
assays	NULL
using	NULL
guanidinium	NULL
isothiocyanate	NULL
.	NULL

Biotechniques	NULL
.	NULL

15	NULL
:	NULL
226-227	NULL
.	NULL

Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
1970	NULL
.	NULL

Cleavage	NULL
of	NULL
structural	NULL
proteins	NULL
during	NULL
the	NULL
assembly	NULL
of	NULL
the	NULL
head	NULL
of	NULL
bacteriophage	NULL
T4	NULL
.	NULL

Nature	NULL
.	NULL

227	NULL
:	NULL
680-685	NULL
.	NULL

Moulton	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
K.	NULL
Semple	NULL
,	NULL
H.	NULL
Wu	NULL
,	NULL
and	NULL
C.	NULL
K.	NULL
Glass	NULL
.	NULL

1994	NULL
.	NULL

Cell-	NULL
specific	NULL
expression	NULL
of	NULL
the	NULL
macrophage	NULL
scavenger	NULL
receptor	NULL
gene	NULL
is	NULL
dependent	NULL
on	NULL
PU.1	NULL
and	NULL
a	NULL
composite	NULL
AP-1/	NULL
ets	NULL
motif	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
:	NULL
4408-4418	NULL
.	NULL

Wu	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
S.	NULL
Moulton	NULL
,	NULL
A.	NULL
Horvai	NULL
,	NULL
S.	NULL
Parik	NULL
,	NULL
and	NULL
C.	NULL
K.	NULL
Glass	NULL
.	NULL

1994	NULL
.	NULL

Combinatorial	NULL
interactions	NULL
between	NULL
AP-1	NULL
and	NULL
ets	NULL
domain	NULL
proteins	NULL
contribute	NULL
to	NULL
the	NULL
developmental	NULL
regulation	NULL
of	NULL
the	NULL
macrophage	NULL
scavenger	NULL
receptor	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
:	NULL
2129-2139	NULL
.	NULL

Kerkhoff	NULL
,	NULL
E.	NULL
,	NULL
K.	NULL
Bistler	NULL
,	NULL
and	NULL
K.	NULL
Klempnauer	NULL
.	NULL

1991	NULL
.	NULL

Sequence-spe-cific	NULL
DNA	NULL
binding	NULL
by	NULL
Myc	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

88	NULL
:	NULL
4223-4327	NULL
.	NULL

Liu	NULL
,	NULL
F	NULL
,	NULL
and	NULL
M.	NULL
Green	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
specific	NULL
member	NULL
of	NULL
the	NULL
ATF	NULL
transcription	NULL
factor	NULL
family	NULL
can	NULL
mediate	NULL
transcription	NULL
activation	NULL
by	NULL
the	NULL
adenovirus	NULL
Ela	NULL
protein	NULL
.	NULL

Cell	NULL
.	NULL

61	NULL
:	NULL
1217-1224	NULL
.	NULL

Williams	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1991	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
DNA-binding	NULL
and	NULL
activation	NULL
properties	NULL
of	NULL
the	NULL
human	NULL
transcription	NULL
factor	NULL
AP2	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

51	NULL
670-682	NULL
.	NULL

Briggs	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
J.	NULL
T.	NULL
Kadonaga	NULL
,	NULL
S.	NULL
P.	NULL
Bell	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1986	NULL
.	NULL

Purification	NULL
and	NULL
biochemical	NULL
characterization	NULL
of	NULL
the	NULL
promoterspecific	NULL
transcription	NULL
factor	NULL
,	NULL
Spl	NULL
.	NULL

Science	NULL
234	NULL
:	NULL
47-52	NULL
.	NULL

Klemsz	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
S.	NULL
R.	NULL
McKercher	NULL
,	NULL
A.	NULL
Celada	NULL
,	NULL
C.	NULL
VanBeveren	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Maki	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
macrophage	NULL
and	NULL
B	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
PU.1	NULL
is	NULL
related	NULL
to	NULL
the	NULL
ets	NULL
oncogene	NULL
.	NULL

Cell	NULL
.	NULL

61	NULL
:	NULL
113-124	NULL
.	NULL

Bucher	NULL
,	NULL
P.	NULL
1990	NULL
.	NULL

Weight	NULL
matrix	NULL
descriptions	NULL
of	NULL
four	NULL
eukaryotic	NULL
RNA	NULL
polymerase	NULL
II	NULL
promoter	NULL
elements	NULL
derived	NULL
from	NULL
502	NULL
unrelated	NULL
promoter	NULL
sequences	NULL
.	NULL

J	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

212	NULL
:	NULL
563-578	NULL
.	NULL

Dynan	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1983	NULL
.	NULL

The	NULL
promoter-specific	NULL
transcription	NULL
factor	NULL
Sp1	NULL
binds	NULL
to	NULL
upstream	NULL
sequences	NULL
in	NULL
the	NULL
SV40	NULL
early	NULL
promoter	NULL
.	NULL

Cell	NULL
.	NULL

351	NULL
79-87	NULL
.	NULL

Anderson	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
and	NULL
S.	NULL
O.	NULL
Freytag	NULL
.	NULL

1991	NULL
.	NULL

Synergistic	NULL
activation	NULL
of	NULL
a	NULL
human	NULL
promoter	NULL
in	NULL
vivo	NULL
by	NULL
transcription	NULL
factor	NULL
Sp1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

111	NULL
1935-1943	NULL
.	NULL

Journal	NULL
of	NULL
Lipid	NULL
Research	NULL
Volume	NULL
40	NULL
,	NULL
1999	NULL
39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

Spanopoulou	NULL
,	NULL
E.	NULL
,	NULL
V.	NULL
Giguere	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
functional	NULL
domains	NULL
of	NULL
the	NULL
murine	NULL
Thy-1	NULL
gene	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
:	NULL
2216-2228	NULL
.	NULL

Saffer	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
S.	NULL
P.	NULL
Jackson	NULL
,	NULL
and	NULL
M.	NULL
B.	NULL
Amarella	NULL
.	NULL

1991	NULL
.	NULL

Developmental	NULL
expression	NULL
of	NULL
Sp1	NULL
in	NULL
the	NULL
mouse	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
:	NULL
2189-2199	NULL
.	NULL

Borellini	NULL
,	NULL
E.	NULL
,	NULL
Y	NULL
F.	NULL
He	NULL
,	NULL
H.	NULL
Aquino	NULL
,	NULL
G.	NULL
Yu	NULL
,	NULL
S.	NULL
F.	NULL
Josephs	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Glatzer	NULL
.	NULL

1991	NULL
.	NULL

Increased	NULL
DNA	NULL
binding	NULL
and	NULL
transcriptional	NULL
activity	NULL
associated	NULL
with	NULL
transcription	NULL
factor	NULL
Spl	NULL
in	NULL
K562	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
myeloid-specific	NULL
cfes	NULL
tyrosine	NULL
kinase	NULL
gene	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chen	NULL
.	NULL

266	NULL
:	NULL
15850-15854	NULL
.	NULL

Schauffel	NULL
,	NULL
F.	NULL
,	NULL
B.	NULL
L.	NULL
West	NULL
,	NULL
and	NULL
T.	NULL
L.	NULL
Reudelhuber	NULL
.	NULL

1990	NULL
.	NULL

Overlapping	NULL
Pit-1	NULL
and	NULL
Sp1	NULL
binding	NULL
sites	NULL
are	NULL
both	NULL
essential	NULL
to	NULL
full	NULL
rat	NULL
growth	NULL
hormone	NULL
gene	NULL
promoter	NULL
activity	NULL
despite	NULL
mutually	NULL
exclusive	NULL
Pit-1	NULL
and	NULL
Sp1	NULL
binding	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chen	NULL
.	NULL

265	NULL
:	NULL
17189-17196	NULL
.	NULL

Jackson	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1988	NULL
.	NULL

O-glycosylation	NULL
of	NULL
eukaryotic	NULL
transcription	NULL
factors	NULL
:	NULL
implications	NULL
for	NULL
mechanisms	NULL
of	NULL
transcriptional	NULL
regulation	NULL
.	NULL

Cell	NULL
.	NULL

55	NULL
:	NULL
125-133	NULL
.	NULL

Alemany	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
E.	NULL
Klement	NULL
,	NULL
T.	NULL
Borras	NULL
,	NULL
and	NULL
F.	NULL
DePablo	NULL
.	NULL

1992	NULL
.	NULL

DNA	NULL
binding	NULL
factors	NULL
which	NULL
interact	NULL
with	NULL
the	NULL
Spl	NULL
site	NULL
of	NULL
the	NULL
chicken	NULL
delta	NULL
l-	NULL
<	NULL
crystallin	NULL
promoter	NULL
are	NULL
developmentally	NULL
regulated	NULL
.	NULL

Bio-chem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

183	NULL
:	NULL
659-665	NULL
.	NULL

Chen	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
H.	NULL
L.	NULL
Pahl	NULL
,	NULL
R.	NULL
J.	NULL
Scheibe	NULL
,	NULL
D.	NULL
E.	NULL
Zhang	NULL
,	NULL
and	NULL
D.	NULL
G.	NULL
Tenen	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
Sp1	NULL
transcription	NULL
factor	NULL
binds	NULL
the	NULL
CD11b	NULL
promoter	NULL
specifically	NULL
in	NULL
myeloid	NULL
cells	NULL
in	NULL
vivo	NULL
and	NULL
is	NULL
essential	NULL
for	NULL
myeloid-specific	NULL
promoter	NULL
activity	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
:	NULL
8230-8239	NULL
.	NULL

Zhang	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
C.	NULL
J.	NULL
Hetherington	NULL
,	NULL
S.	NULL
Tan	NULL
,	NULL
S.	NULL
E.	NULL
Dziemis	NULL
,	NULL
D.	NULL
A.	NULL
Gonzalez	NULL
,	NULL
H.	NULL
Chen	NULL
,	NULL
and	NULL
D.	NULL
G.	NULL
Tenen	NULL
.	NULL

1994	NULL
.	NULL

Sp1	NULL
is	NULL
a	NULL
critical	NULL
factor	NULL
for	NULL
the	NULL
monocytic	NULL
specific	NULL
expression	NULL
of	NULL
human	NULL
CD14	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

269	NULL
:	NULL
11425-11434	NULL
.	NULL

Ray	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
and	NULL
A.	NULL
Ray	NULL
.	NULL

1994	NULL
.	NULL

Spl-mediated	NULL
transactivation	NULL
of	NULL
the	NULL
rabbit	NULL
alpha	NULL
1	NULL
acid	NULL
glycoprotein-encoding	NULL
gene	NULL
involves	NULL
a	NULL
cisact-ing	NULL
element	NULL
in	NULL
the	NULL
5'-proximal	NULL
promoter	NULL
region	NULL
.	NULL

Gare	NULL
147	NULL
:	NULL
253-257	NULL
.	NULL

Zutter	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
E.	NULL
E.	NULL
Ryan	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Painter	NULL
.	NULL

1997	NULL
.	NULL

Binding	NULL
of	NULL
phos-phorylated	NULL
Spl	NULL
protein	NULL
to	NULL
tandem	NULL
Spl	NULL
binding	NULL
sites	NULL
regulates	NULL
alpha	NULL
?	NULL

integrin	NULL
gene	NULL
core	NULL
promoter	NULL
activity	NULL
.	NULL

Blood	NULL
.	NULL

90	NULL
:	NULL
678-689	NULL
.	NULL

D'Angelo	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
B.	NULL
G.	NULL
Oliver	NULL
,	NULL
M.	NULL
G.	NULL
Davis	NULL
,	NULL
T.	NULL
S.	NULL
McCluskey	NULL
,	NULL
and	NULL
G.	NULL
W.	NULL
Dorn	NULL
.	NULL

1996	NULL
.	NULL

Novel	NULL
role	NULL
for	NULL
Spl	NULL
in	NULL
phorbol	NULL
ester	NULL
enhancement	NULL
of	NULL
human	NULL
platelet	NULL
thromboxane	NULL
receptor	NULL
gene	NULL
expression	NULL
.	NULL

J	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

2711	NULL
:	NULL
19696-19704	NULL
.	NULL

Williams	NULL
,	NULL
T.	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
B.	NULL
Luscher	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1988	NULL
.	NULL

Cloning	NULL
and	NULL
expression	NULL
of	NULL
AP-2	NULL
,	NULL
a	NULL
cell-type-specific	NULL
transcription	NULL
factor	NULL
that	NULL
activates	NULL
inducible	NULL
enhancer	NULL
elements	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

2	NULL
:	NULL
1557-1569	NULL
.	NULL

Imagawa	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
Chiu	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1987	NULL
.	NULL

Transcription	NULL
factor	NULL
AP-2	NULL
mediates	NULL
induction	NULL
by	NULL
two	NULL
different	NULL
signal-transduction	NULL
path-ways	NULL
:	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
cAMP	NULL
.	NULL

Cell	NULL
.	NULL

51	NULL
:	NULL
251-260	NULL
.	NULL

Luscher	NULL
,	NULL
B.	NULL
,	NULL
P.	NULL
J.	NULL
Mitchell	NULL
,	NULL
T.	NULL
Williams	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1989	NULL
.	NULL

Regulation	NULL
of	NULL
transcription	NULL
factor	NULL
AP2	NULL
by	NULL
the	NULL
morphogen	NULL
retinoic	NULL
acid	NULL
and	NULL
by	NULL
second	NULL
messengers	NULL
.	NULL

Genes	NULL
&	NULL
Dev	NULL
.	NULL

3	NULL
:	NULL
1507-1517	NULL
.	NULL

Buettner	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Kannau	NULL
,	NULL
A.	NULL
Imhof	NULL
,	NULL
R.	NULL
Bauer	NULL
,	NULL
S.	NULL
O.	NULL
Yim	NULL
,	NULL
R.	NULL
Glocks-huber	NULL
,	NULL
M.	NULL
W.	NULL
Van	NULL
Dyke	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Tainsky	NULL
.	NULL

1993	NULL
.	NULL

An	NULL
alternatively	NULL
spliced	NULL
mRNA	NULL
from	NULL
the	NULL
AP-2	NULL
gene	NULL
encodes	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
transcriptional	NULL
activation	NULL
by	NULL
AP-2	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
:	NULL
4174-4185	NULL
.	NULL

Moser	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Imhof	NULL
,	NULL
A.	NULL
Pscherer	NULL
,	NULL
R.	NULL
Bauer	NULL
,	NULL
W.	NULL
Amselgruber	NULL
,	NULL
F.	NULL
Sinowatz	NULL
,	NULL
F.	NULL
Hofstidter	NULL
,	NULL
R.	NULL
Schille	NULL
,	NULL
and	NULL
R.	NULL
Buettner	NULL
.	NULL

1995	NULL
.	NULL

Cloning	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
second	NULL
AP-2	NULL
transcription	NULL
factor	NULL
:	NULL
AP2	NULL
beta	NULL
.	NULL

Development	NULL
.	NULL

121	NULL
:	NULL
2779-2788	NULL
.	NULL

6loz	NULL
'	NULL
o	NULL
)	NULL
Aepy	NULL
uo	NULL
qsanB	NULL
Aq	NULL
Buo'jj	NULL
[	NULL
'mmm	NULL
wou	NULL
;	NULL
papeojumog	NULL

